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Thesis word count:    23,952 
 
 




Aims: There is a well-established link between asthma and anxiety, leading to exacerbations 
for both conditions. National guidelines and policy documents recommend the provision of 
psychological interventions for this comorbidity, although evidence for their effectiveness is 
inconclusive. This thesis had two objectives: a) to evaluate cognitive-behavioural therapy 
(CBT) interventions for reducing anxiety in adults and/or children with asthma, given that 
CBT has a stronger evidence base for relevant respiratory and mental health conditions, b) to 
explore the lived experience of the interplay between childhood asthma and anxiety directly 
from the affected population in order to identify specific thinking and behaviour patterns that 
may maintain this comorbidity. 
Method: The first journal article outlined a systematic review. Three major electronic 
databases and manual searches were used to find relevant published and unpublished 
research. Trials meeting inclusion criteria, primarily utilising validated anxiety measures and 
employing both cognitive and behavioural techniques, were evaluated using adapted quality 
criteria. The second empirical article implemented interpretative phenomenological analysis 
(IPA) to explore the mechanisms maintaining the interplay between asthma and anxiety as 
experienced by 11 young people (aged 11-15) living with the comorbidity. 
Results: Fourteen trials met the inclusion criteria for the systematic review. The reviewed 
trials showed reasonable preliminary support for the effectiveness of CBT for anxiety in 
individuals with asthma across the age range. The favourable results were largely maintained 
long-term. The empirical article revealed three super-ordinate themes: i) ‘the influence of 
asthma’ by inhibiting valued activities or developmental tasks, triggering catastrophic 
thinking and leading to a generalisation of asthma coping strategies to managing anxiety; ii) 
‘the influence of anxiety’ by affecting appropriate medication use and triggering 
hyperventilation-induced asthma exacerbations;  and iii) ‘the interaction between asthma and 
anxiety’ by forming an unhelpful positive feedback loop and triggering symptom confusion. 
Conclusions: The systematic review discussed the moderate overall study quality and called 
for more methodologically robust research, examining CBT models tailored to this 
population and utilising clinically representative samples. The empirical article pointed to 
possible maintaining mechanisms identified, which lend themselves to a cognitive-
behavioural framework, potentially including mindfulness-based interventions, and may be 
used to tailor psychological treatments. 
 
 
                                                          
1 This systematic review was written in accordance to the guidance of the Journal of Anxiety 
Disorders (Impact factor 2013: 3.042; SCImago Journal Rank - Clinical Psychology 17/245; see Appendix 
A for author instructions). Adaptations were made due to this document being submitted as part of an 
academic thesis portfolio. Figures, flowcharts and tables were, thus, included in the main text, rather than 
separately in a different file or at the end of the main text; an appendix expanding on the systematic review 
quality criteria was also included.  
Word Count: 5948 (excl. abstract, tables, figures, references) 
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There is a well-established interplay between asthma and anxiety, leading to exacerbations 
for both conditions. This systematic review summarised evidence regarding the effectiveness 
of cognitive-behavioural therapy (CBT) in reducing anxiety in adults and/or children with 
asthma. Fourteen trials meeting inclusion criteria, primarily utilising validated anxiety 
measures and employing both cognitive and behavioural techniques, were evaluated with 
adapted quality criteria. Reasonable preliminary support for the use of CBT for anxiety in 
individuals with asthma was found across the age range. The quality ratings on the treatment 
integrity and sample representativeness criteria determined the review outcomes. The overall 
study quality was moderate, calling for more methodologically robust research, examining 
CBT models tailored to this population and setting recruitment criteria that justify the use of 
anxiety interventions. Future research and guidance need to consider closely defining targeted 
outcomes and treatments to facilitate greater clarity regarding the usefulness of psychological 
interventions in asthma populations. 
Keywords: anxiety, asthma, cognitive-behavioural therapy, systematic review 
Abstract word count: 150 






 The effectiveness of CBT in improving anxiety in individuals with asthma was reviewed 
 Available evidence was summarised and evaluated with purposefully-designed criteria 
 Sampling and intervention rationale were crucial, study quality was moderate  
 Preliminary evidence favoured the use of CBT for anxiety in the context of asthma  
 Results were applicable across the age range and largely maintained long-term 
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Asthma is an inflammatory condition of the airways, which restricts the air passage into the 
lungs, resulting in wheezing, shortness of breath, coughing and chest tightness (Rees, 
Kannabar, & Pattani, 2006). It is the most common chronic health condition (National 
Institute for Health and Care Excellence [NICE], 2013), affecting more than 300 million 
individuals worldwide (Bateman et al., 2008). Over 5.4 million individuals suffer from 
asthma in the UK, one fifth of which are children (NICE, 2013). It is further estimated that 
one patient is hospitalised every seven minutes due to complications related to the disease 
(Asthma UK, 2012). 
Despite medical advances, asthma remains a major contributor to morbidity and mortality 
(Jones et al., 2008). There is a well-established link between asthma and mental health 
difficulties, especially anxiety (Blackman & Gurka, 2007). A review of 12 studies reported a 
prevalence of 6.5 - 24% of panic disorder amongst adults with asthma (Katon, Richardson, 
Lozano, & McCauley 2004). In a large community study of 4181 participants, Goodwin, 
Jacobi, & Thefeld (2003) illustrated that severe asthma symptoms were linked with a higher 
risk of any anxiety disorder and a four-fold higher likelihood of panic disorder (O.R. = 4.61). 
Although amongst adults with asthma, panic disorder seems to be the most prevalent mental 
health comorbidity (Hasler et al., 2005), children with asthma have substantially higher risk 
to develop any anxiety disorder, including separation anxiety, specific phobia, panic and 
generalised anxiety disorder (Gupta, Mitchell, Giuffre, & Crawford, 2001; Ortega, Huertas, , 
Ramirez, & Rubio-Stipec, 2002).  
Despite indicating anxiety as asthma’s most common psychological complication, many of 
the above prevalence studies are limited by recruitment from specialised respiratory clinics. 
This may overemphasize ‘difficult to treat’ asthma and its implications, whilst some studies 




are further restricted by relying on secondary measures of asthma and self-reported symptoms 
of anxiety (Lehrer, Feldman, Giardino, Song, & Schmaling 2002). The relationship between 
asthma and anxiety, however, may not be surprising given the key role of breathing function 
in anxiety (Carr, 1998); although other factors are also important in this comorbidity.  
To be more specific, asthma attacks are particularly aversive, which can reinforce 
anticipatory anxiety or avoidance (Carr, 1998), increase health-related fear and 
hypervigilance regarding threatening bodily symptoms (Feldman, Siddique, Thompson, & 
Lehrer, 2005; Lehrer et al., 2008). Such factors have all been identified by predominant 
psychological models to maintain health anxiety and panic (Clark, 1986; Warwick & 
Salkovskis, 1990). Individuals with asthma and anxiety, in turn, tend to overperceive 
symptoms of asthma and overreact during asthma episodes (De Peuter, Lemaigre, van Diest, 
& van den Bergh, 2008; Main, Moss-Morris, Booth, Kaptein, & Kolbe, 2003). Studies 
including adult samples have confirmed that anxiety predicts overuse of reliever medication 
and increased healthcare use, independently of objective pulmonary function (De Peuter et 
al., 2005; Feldman et al., 2005; Feldman, Siddique, Thompson, & Lehrer, 2009). This results 
in an over-prescription response from medical staff (Fernandes et al., 2010) and in enormous 
costs for the NHS due to unnecessary hospital admissions and primary care use (Hutter, 
Knecht, & Baumeister, 2011; Jones et al., 2008). 
Identifying and treating anxiety in the context of asthma and other respiratory conditions is 
thus of crucial importance. Strategic planning and policy documents in the UK (Department 
of Health [DoH], 2011; 2014; Scottish Government, 2012) and SIGN guidelines (Scottish 
Intercollegiate Guidelines Network, 2012a) recommend the provision of psychological 
interventions for individuals with asthma experiencing complications related to anxiety. It is 
also, however, recognised within such reports that the evidence regarding the potential 




usefulness of psychological interventions in this context is unclear (SIGN, 2012a). 
Only a few reviews have examined the effectiveness of psychological interventions in 
improving anxiety in individuals with asthma. For example, Lehrer, Sargunaraj and Hochron 
(1992) conducted a narrative review on the effectiveness of psychological therapies 
(biofeedback, family therapy, relaxation) in improving psychological and asthma outcomes in 
this context, but have not examined the effect on anxiety. Devine (1996) and Smith and 
colleagues (2005) reviewed the usefulness of psycho-educational input alone in improving 
psychological morbidity for adults and children with asthma, but found limited positive 
results for anxiety.  
More recently, two Cochrane reviews focusing on adults and children respectively (Yorke, 
Fleming, & Shuldham, 2009a; 2009b) examined the effectiveness of psychological 
interventions primarily in improving asthma outcomes, e.g., medication or healthcare use, 
and secondarily in improving psychological functioning, including anxiety. They concluded 
that no sufficient evidence exists for the role of psychological treatments in asthma 
populations (Yorke et al., 2009a; 2009b). It is possible that the reviews were inconclusive 
because of the wide variation of the interventions examined, including biofeedback, hypnosis, 
psycho-education, imaginal and muscle relaxation, or cognitive-behavioural therapy (Yorke 
et al., 2009a; 2009b). Evaluating psychological interventions as a cohesive single construct 
may result in potentially missing therapeutic components or modalities that are critical for 
improving effectiveness.  
The majority of published psychological trials in the context of asthma are designed to 
enhance asthma care and thus aim to support patients manage breathlessness/hyperventilation 
though relaxation and breathing retraining exercises (Freitas et al., 2013; Huntley, White, & 
Ernst, 2002). Reviews on the usefulness of such interventions conclude that outcomes are 




contradictory (Freitas et al., 2013; Huntley et al., 2002). Some studies show improvements in 
psychosocial functioning alone (Chiang, Ma, Huang, Tseng, & Hsueh, 2009), some report a 
reduction in medication use and an improvement in asthma management (Opat, Cohen, 
Bailey, & Abramson, 2000; Thomas et al., 2003), while others report no significant 
contribution of relaxation to asthma management altogether (Lehrer et al., 1994). 
Methodological differences between the above trials may partially account for the 
contradictory findings, although the inconclusive outcomes may also be linked to the 
prescriptive inclusion of psychological techniques without a clear theoretical framework.  
Frequently, psychological interventions for asthma solely focus on improving the 
physiological symptoms of anxiety through relaxation and breathing techniques.  
Respectively, other available treatment protocols may solely focus on improving some 
cognitive aspects of the comorbidity, targeting health worries and aiming to change asthma 
illness perceptions (Kaptein, Klok, Moss-Morris, & Brand, 2010). Anxiety, however, is 
determined by an interaction of cognitive, emotional, physiological and behavioural factors 
(Seligman, Walker, & Rosenhan, 2001) and all need to be addressed in a comprehensive 
model in order to improve long-term outcomes. 
Cognitive-behavioural therapies (CBT) appear suitable in this respect and a significant body 
of evidence supports their effectiveness in improving anxiety in individuals without a medical 
comorbidity (NICE, 2011; Scottish Government, 2011). There is also empirical support for 
the use of CBT in reducing anxiety within other chronic respiratory conditions, such as 
chronic obstructive pulmonary disease (Livermore, Sharpe, & McKenzie, 2010).  
No review to date has been published examining the effectiveness of CBT alone for anxiety 
in individuals with asthma. Most studies included in the relevant Cochrane reviews (Yorke et 
al., 2009a; 2009b) involved broadly defined psychological techniques, such as biofeedback or 




relaxation, to address the physiological symptoms of anxiety, without targeting other aspects 
of the phenomenology of anxiety and the factors that psychological research has identified to 
maintain it (e.g., cognitive or emotional factors or safety-seeking behaviours) (Seligman et 
al., 2001). Only three CBT trials met standards for inclusion in the relevant Cochrane review 
on adults and two on children (Yorke et al., 2009a; 2009b), with some positive outcomes, but 
not enough to evidence the effectiveness of this treatment mode for anxiety. These reviews 
did not include other study designs, such as non-randomised, quasi experimental studies, 
although given the limited number of good quality randomised controlled trials (RCTs) in 
this field, the inclusion of other study designs would help address whether CBT is effective 
with anxiety in asthma populations.  
1.1. Aim 
The present review aims to systematically evaluate available evidence regarding the 
effectiveness of cognitive-behavioural interventions alone in reducing anxiety in adults 
and/or children and adolescents with asthma. 
2. Method  
2.1. Search strategy 
The systematic search was conducted in July 2014. Initially, the Cochrane database was 
searched to explore relevant systematic reviews in the field and ensure that no similar review 
was recently undertaken. Subsequently, the following databases were searched: Ovid Medline 
(1946-2014), PsychInfo (1806-2014) and Embase (1974-2014). The terms used to search for 
keywords in all fields included: CBT or cognit* therap* or behav* therap* or cognitive-
behav* therap* or problem-solving therap* and anx* and asthma* (where *allowed the 
inclusion of variations in spellings and word endings). The search was focussed on work 




published in English due to limited resources for translation.  
Further to the initial search method, manual searches were also undertaken to reduce potential 
limitations associated with the selection of these keywords. All papers referenced in the 
originally identified studies and the relevant Cochrane reviews (Yorke et al., 2009a; 2009b) 
were examined. Moreover, subsequent publications which cited the included studies, as they 
appear in the Google Scholar search engine, were also screened. Key journals in the field 
were further searched, including the Journal of Anxiety Disorders, Psychosomatic Medicine, 
European Respiratory Journal and Respiratory Medicine. To address publication bias web 
searches and searches in citations of included papers for unpublished documents, conference 
presentations and dissertations were also conducted. Key authors (e.g., Lehrer, Grover) were 
contacted for suggesting relevant work. 
2.2. Inclusion and exclusion criteria 
Guidance from the Centre for Reviews and Dissemination (CRD, 2009) and the PRISMA 
statement (Liberati et al., 2009) was followed to conduct and report the current review. The 
inclusion and exclusion criteria were thus determined based on the ‘PICOS’ approach: 
population, interventions, comparators, outcomes and study design (CRD, 2009).  
2.2.1. Population 
Included studies had participants with a diagnosis of asthma. No limitations were set on the 
severity of asthma symptomatology or on the diagnostic method/criteria. All types and levels 
of severity of anxiety symptomatology at baseline were included. Larger scale studies 
involving populations with other chronic medical/respiratory/mental health conditions were 
eligible, if results for asthma and anxiety were presented separately. No age, gender or other 
limitations on the included population were stipulated.  





 Included studies examined CBT interventions that involved both cognitive and behavioural 
components as outlined by Butler and colleagues in their review of the empirical status of 
CBT (Butler, Chapman, Forman, & Beck 2005). Therefore, studies examining the 
effectiveness of behavioural only interventions, e.g. progressive muscle relaxation, were not 
eligible for this review. Anxiety improvement was a primary or secondary treatment goal in 
all studies. All intervention formats were eligible (e.g. individual and group treatment 
protocols, computerised or self-help interventions). No exclusions were set based on the level 
of therapist input, length or number of sessions. Studies providing additional input to 
significant others (parents or partners) were also eligible.  
 2.2.3. Outcome 
Studies were eligible only if severity of anxiety symptomatology was assessed at baseline and 
at post-treatment using a standardised measure (validated observation, interview protocol or 
self-report tool).  
2.2.4. Study design and comparators 
Despite the generally higher quality of empirical support provided by randomised controlled 
trials (Sibbald & Ronald, 1998), other study designs were also eligible due to the restricted 
number of high quality RCTs in this field. Thus, non-randomised controlled trials and 
observational repeated-measures designs without controls were also included. Case studies 
were excluded due to the presence of a sufficient number of studies meeting higher quality 
standards. No specifications were set for the comparative conditions eligible for inclusion, 
e.g., treatment as usual, wait-list, placebo controls.  
 




2.3. Quality criteria 
The methodological quality of the eligible studies was assessed using quality criteria 
developed for the purposes of this review (Table 1; see Appendix B for an operationalisation 
of the criteria). Existing quality criteria were reviewed but appeared unsuitable for the aims 
of the current review, mainly due to the methodological variation between the eligible 
studies, including non-randomised controlled trials or observational studies. In addition, the 
idiosyncrasies of the treatment protocols and participants’ clinical characteristics required 
specifically designed criteria to address them. The absence of power calculations in the 
majority of the studies also suggested the need to calculate this as part of the quality criteria, 
especially after determining a realistic effect size and evaluating each study based on this.  
Several authors suggest that available quality criteria may need to be adjusted to ensure that 
they address the requirements of specific review questions (Coull & Morris, 2011; Mayo-
Wilson & Montgomery, 2007). Major and internationally recognised guidelines, however, 
were closely consulted to develop the present quality criteria to meet the aims of this 
systematic review: the SIGN 50 Checklist for RCTs (SIGN, 2012b), the Consolidated 
standards of reporting trials (Schulz, Altman & Moher, 2010) and guidance from the Centre 
for Reviews and Dissemination (2009).  
SIGN guidance (2012b) was followed for the ratings of each quality criterion: well covered 
(3 points), adequately addressed (2), poorly addressed (1) and not addressed (0). The highest 
possible score was 36. Guidance on conducting and reporting systematic reviews (Liberati et 
al., 2009) suggests that summarising outcomes on multiple criteria in a single arithmetic 
value alone can be misleading, especially as the criteria are not truly equally weighted. Thus, 
the overall rating was also given with a quality classification of ++, + or - (SIGN, 2012b), 
based on whether the overall rating ranged above the 75% (27-36), above 50% (18-26) or 




below 50% (0-17) of the highest possible rating.  
 
 
Table 1. Quality Criteria used to rate Reviewed Studies 
 
Quality criteria 
1. Study design provides sufficient evidence that the anxiety outcomes are due to the intervention 
2. Recruitment method and inclusion criteria are appropriate to ensure a representative and suitable sample 
3. Sample size (power) is sufficient for analysis relating to pre and post anxiety outcomes 
4. Allocation process is appropriate to address allocation bias 
5. Groups are comparable at baseline on key variables (i.e., asthma or anxiety severity, age, gender) 
6. Measures of anxiety are robust, appropriately administered and well-validated  
7. Follow-up measures are administered to evaluate if effects are maintained long-term 
8. Treatment protocol is suitable for improving anxiety outcomes in the context of asthma 
9. Intervention is appropriately conducted and adherence to protocol is suitably assessed 
10. Analysis is appropriate for the study aims, measures or design and outcomes are appropriately reported 
11. Attrition rates are low or comparable to control group 
12. Method to address missing data is suitable 
 
3. Results 
3.1. Study inclusion  
The electronic database search method yielded 1681 results. Duplicates were removed and 
the remaining papers were screened against the eligibility criteria. Figure 1 presents a 
flowchart of the search pathway, its outcomes and the reasons for exclusion of reviewed 
studies. One paper was irretrievable (Grover, Kumaraiah, Prasadrao, & D'Souza 2002), 
despite library requests and contacting the author. Manual search produced two more results. 
A total of 13 papers were identified to meet all the inclusion criteria for this review. One 
paper described two different trials, each one of which independently met the eligibility 
criteria; hence, a total of 14 studies were included. 
 




Figure 1. Flowchart of search strategy pathway and results 
 
3.2. Quality assessment 
All studies were rated based on the quality criteria purposefully developed for this review 
(Table 3). The second author independently evaluated the quality of a randomly selected third 




(n = 5) of included studies using a randomised sequence generated by random.org. This 
yielded an agreement on 50/60 ratings (83.3%). Disagreement of more than one point was 
found in four ratings, with these discrepancies being discussed between both raters, and the 
criteria amended as necessary to increase clarity and consistency. 
3.3. General characteristics of the studies 
A summary of key characteristics of the studies included in this review is provided in Table 
2. Ten studies recruited adult participants (aged 18 years or above) and these were presented 
and analysed separately from the four studies recruiting children and adolescents, as the 
treatment components are frequently different or adjusted for these age groups (Sauter, 
Heyne, & Westenberg, 2009). Overall, the study quality was moderate with significant 
variation amongst included trials. To answer the review question there were several aspects 
of the trials that were pertinent: the study design, the sample power and representativeness, 
the suitability of the intervention and the outcome measures used.   
3.4. Adults 
3.4.1. Study design 
Of the 10 trials involving adult participants, six were RCTs, one was a non-randomised 
controlled trial and three uncontrolled repeated-measures designs (Table 2). Three of the 
RCTs were allocated the highest rating (++) (Campbell-Sills et al., 2013; Parry et al., 2012; 
Ross, Davis, & MacDonalds, 2005), with the rest of the controlled trials allocated the next 
highest rating (+) (Sommaruga et al., 1995; Put et al., 2003; and Maes & Schloser, 1988). 
Even amongst highly rated studies, there were poor ratings in specific quality criteria 
indicating some methodological limitation in relation to the current review question (Table 
3).  




Table 2. Characteristics and key findings of included studies 
Study 
Reference 
























CBT for  
asthma-specific fear 
5-9 individual sessions 
with a clinical psychologist 
or a CBT therapist 
Treatment fidelity assessed 
through peer supervision & 
recordings of sessions 
standard 
care 
n = 50 
Mean age = 47 
Female = 61% 
severe asthma = 
39% 
n = 44 
Mean age = 
43.8 
Female = 65% 











A significantly greater 
improvement in asthma-specific 
anxiety was found for the CBT 
group as compared to controls at 
post-treatment, which increased 
at 6-months. 
No statistically significant 
differences between groups were 




d = 0.32  
High drop-out in CBT 
group. 
22% of the CBT group 
were still in the clinical 
range for asthma-













Minimum 10-12 individual 
sessions & minimum 1 
intervention contact with 
















6, 12, 18 
months 
Significant improvements on 
anxiety symptoms were found in 
both groups over time. 
There were no statistically 




d ≈ 0.70 
No descriptive, 
demographic & clinical 
data reported between 
groups 
No reported therapist 
training & experience 
++ 
28/36 




Asthma education & CBT 
for panic 
12 group sessions with 
doctoral nurses 
Session-by-session 
protocol & treatment 
fidelity assessed by rating 





n = 15 
Mean age = 37 




Mean = 6.80 
n = 10 
Mean age = 40 
Female = 100% 
self-rated 
















improvements were found in 
panic frequency, general anxiety 
& anxiety sensitivity for the CBT 
group as compared to controls. 
Only the panic frequency results 
were maintained at 6-months. 
There was no difference between 
groups in agoraphobic avoidance. 
SPRAS  
d = 1.86 
ASI 
d = 1.43 
FQ – 
agoraph. 
d = 0.52 
Small sample size 





et al. (1995) 
Italy 
RCT 
Asthma education & CBT 
3-6 individual CBT 




n = 20 
Mean age = 44 
Female = 45% 
asthma severity: 
inpatients 
n = 20 
Mean age = 51 












The CBT group showed 
statistically significant 
improvements in anxiety & 
psycho-physiological symptoms 
at 12 months, which were higher 




d = 0.67 
QPF 
d = 0.38 
Convenience sampling 
No reported assessment 


































facilitated by a workbook 




n = 12 
Mean age = 43 
Female = 42% 
mild -moderate 
asthma 
n = 11 
Mean age = 48 
Female = 62% 







No statistically significant 
differences on the ASC anxiety 
subscale within the intervention 
group at post-treatment & follow-
up and between groups. 
ASC – 
anxiety 
d = 0.42 
Small sample size 
No reported assessment 










Four weeks of self-help 
CBT with audio-taped 
relaxation tasks & 20min 
exercises writing about 
stressful events 




n = 27 
Mean age = 
21.7 
Female = 56% 
self-rated health 
(0-6)  
Mean = 4.48 
n = 27 
Mean age = 
19.67 
Female = 52% 
self-rated health 
(0-6) 
Mean = 4.63 
PSS none 
No statistically significant 
differences in PSS levels were 
found over time or between 
groups. 
PSS  
d = 0.46 
Convenience sampling 
PSS assessed stress 
levels over treatment 
period 











Asthma education & CBT 
8 weekly, 2-3h group 
sessions with patients & 
partners, facilitated by a 
health psychologist & 
other health professionals. 
standard 
care 









A statistically greater 
improvement in general anxiety 
was found for the CBT group as 
compared to controls, but not in 




d = 0.38 
STAI trait 
anxiety 
d = 1.33 
Small sample size 
Convenience sampling 
Participants not 
randomised in groups 
No follow-up or 
assessment of fidelity 
+ 
18/36 







Asthma education & CBT 
for panic 




n = 12 
Mean age = 31 









1 & 2 
months 
Significant decreases were found 
on panic & general anxiety scores 
at post-treatment & follow-ups. 
PDSS effect sizes were large at 
post-treatment & follow-up, but 
in BAI were small to medium at 
post-treatment & follow-up. 
PDSS  
d = 1.16 
ASI  
d = 0.68 
BAI 
d = 0.48 
BSQ  
d = 0.60 
Small sample size 
No control condition 
No reported assessment 
of treatment fidelity 
No reported therapist 
training & experience 
- 
16/36 







Asthma education & CBT 
for panic 




n = 10 
Mean age = 
44.1 








1 & 2 
months 
Significant decreases were found 
on panic & general anxiety scores 
at post-treatment & follow-ups. 
PDSS and BAI effect sizes 
remained large at post-treatment 
& follow-up 
PDSS  
d = 1.01 
ASI  
d = 0.19 
BAI 
d = 1.21 
BSQ  
d = 0.72 
Small sample size 
No control condition 
High drop-out (50%) 
No reported assessment 
of treatment fidelity 
No reported therapist 












CBT focused on health 
perceptions & reactions 
8 group sessions with 
qualified counsellors 
none 
n = 29 
Mean age = 
51.8 









A statistically significant 
improvement in anxiety was 




d = 1.30 
HADS not administered 
to control group 
available in study 
No reported assessment 
of  treatment fidelity 
- 
14/36 






























training & CBT with 
homework assisted by 
parents 
10 group sessions with a 
behaviour therapist & a 
group psychotherapist 
control 






n = 48 
Mean age = 10 
Female = 39% 
na = 34 
nb = 30 
Mean age = 
a & b 10 
Females 
a & b=38.9% 
STAI-
children 
1, 6, 12 
months 
Significantly greater reductions in 
general & asthma-specific anxiety 
were found at post-treatment in 
the CBT group versus controls. 
Only the difference on the 
asthma-specific anxiety remained 
significant at 6-month. 
STAI 
d = 0.52 
No reported assessment 












CBT for anxiety 
12 group or individual 
sessions with psychiatrists 

















n = 36 
8-12 years 





A statistically significant 
reduction in anxiety was found in 
both groups at post treatment. A 
trend (not statistically significant) 
towards less improvement in total 
anxiety was found for children 
with asthma as compared to 
children without asthma. 
Physiological anxiety increased 
for the asthma group compared to 
the group without asthma. 
RCMAS 
d ≈ 0.14 
No follow-up measures 
No reported results 
separately for group or 
individual sessions 













Asthma education & CBT 
with physiological 
feedback & relaxation 
6 individual sessions with 
graduate CBT therapists, 
MSc clinicians & research 
assistants 
Session-by-session 
protocol & weekly 
supervision 
none 
n = 22 
(trial 1 n=14 
trial 2 n=8) 
7-12 years 













improvements were found in PSS 
& anxious mood at post-
treatment, but not for the state-
trait anxiety measure. 
PSS 
d = 1.65 
POMS - 
anxiety 
d = 0.59 
STAI trait 
anxiety 
d = 0.40 
STAI state 
anxiety 
d = 0.004 
No follow-up measures 
No control condition 











Asthma education & CBT 
with mindfulness 
6 group sessions with a 
respiratory nurse specialist 
trained in behavioural 
techniques 
none 
n = 17 
Mean age = 
14.2 




3 & 6 
months 
A reduction of up to 30% on 
anxiety scores was found at post-





High dropout, not 
addressed in analysis 
Convenience sample 
No  reported assessment 
of treatment fidelity 
- 
14/36 
Abbreviations: BSI: Brief Symptom Inventory; PSS: Perceived Stress Scale; PDSS: Panic disorder severity Scale; ASI: Anxiety Sensitivity Index; ACQ: Agoraphobic Cognitions Questionnaire; BSQ: Body Sensations 
Questionnaire; BAI: Beck Anxiety Inventory; STAI: State Trait Anxiety Inventory; ASC: Asthma Symptom Checklist; HADS: Hospital Anxiety & Depression Scale; FQ: Fear questionnaire; SPRAS: Sheehan Patient-Rated 
Anxiety Scale; CBA: Cognitive Behavioural Assessment Batteries; QPF: Psycho-physiological symptoms; POMS: Profile of mood states; SCAS: Spence Children’s’ Anxiety Scale; RCMAS: Revised Children’s Manifest 
Anxiety Scale.  
aCohen (1988) suggested interpreting effect sizes as small d = .2, medium d = .5, and large d = .8. 




Table 3. Quality ratings of methodological ability to address review question 
 









































































































































































































































































































































































































































3.4.2. Sample representativeness and power 
Of the trials that reported descriptive statistics (Table 2), the mean age of participants ranged 
between 21.7 and 51.8 years. Sample sizes were generally low and for the intervention 
condition ranged between 10 and 50 participants. Attrition rates for the intervention groups 
were moderate overall (≤40%), but ranged between 0%-50%.  
The majority of the trials (n = 9) adopted suitable analyses to examine effect over time and 
differences between conditions, but had not outlined a power calculation (n = 7). The first 
author computed a post-hoc power analysis for the pre-post results of the intervention group 
of each trial (for reasons of consistency across studies) using the G*power programme and 
estimating effect size to be medium (d = 0.5 for t-test; f = 0.25 for ANOVA) and alpha 0.05. 
Most of the reviewed studies (n = 9) achieved power of less than 0.8. Campbell-Sills and 
colleagues (2013) were rated higher in terms of sample power for their analysis. The sample 
representativeness in this study, however, was only adequately rated due not examining 
asthma severity and not excluding mental health co-morbidities.  
Recruitment methods and eligibility criteria varied substantially between the reviewed 
studies. Two studies used convenience samples of inpatients admitted in a single department 
at the time of the study (Sommaruga et al., 1995), or volunteer college students who were 
telephone screened for asthma (Hockemeyer & Smyth, 2002), without applying any other 
specific criteria that would allow to generalise conclusions based on their outcomes. The 
remaining studies were based on representative respiratory populations recruited by multiple 
specialist services, chronic disease registers, or primary care services, who had a physician-
confirmed asthma diagnosis. However, out of these eight trials, only five recruited 
participants, who were also screened for the presence of anxiety symptomatology (Campbell-
Sills et al., 2013; Lehrer et al., 2008a; 2008b; Parry et al., 2012; Ross et al., 2005) using 




validated methods and who would benefit from an anxiety psychological intervention. These 
were rated higher on sample representativeness. Maes and Schloser (1988) recruited 
participants that were asthma medication over-users and thus potentially suitable for anxiety 
management input, if over-use was triggered by anxiety (Feldman et al., 2009), although this 
was not examined.  
3.4.3. Outcome measures  
Hockemeyer and Smyth (2002) used a robust measure for anxiety, but it was rated poorly as 
the post-evaluation instructions referred to the treatment period - rather than the post-
treatment period, during which anxiety would be expected to be similar to baseline or even 
elevated. All other studies used at least one well-validated and reliable anxiety measure and 
administered it appropriately. Four trials included the HADS (Zigmond & Snaith, 1983) 
and/or the anxiety subscale of the ASC (Kinsman, Luparello, O'Banion, & Spector, 1973), 
which are arguably particularly well-suited to measuring psychological functioning in the 
context of chronic respiratory conditions. Most studies (n = 8) followed outcomes long term. 
3.4.4. Interventions 
Five interventions were delivered in a group and three in an individual format (Table 2), 
offering from 3 to 14 therapist sessions. Two studies offered a minimum number of either one 
(Campbell-Sills et al., 2013) or no therapist sessions (Hockemeyer & Smyth, 2002). 
Significant variation existed between the background training and clinical experience of 
therapists, which was only reported in six of the trials. This ranged from clinical or health 
psychologists and CBT therapists (Maes & Schloser, 1988; Parry et al., 2012) to doctoral 
nurses (Ross et al., 2005), psychologists and psychology researchers (Put et al., 2003; 
Sommaruga et al., 1995) or counsellors (Spurgeon et al., 2005). Examination of adherence to 
treatment protocol was sufficiently addressed only by Parry and colleagues (2012) and Ross 




and colleagues (2005).  
Six of the interventions were designed to reduce anxiety as one of their primary aims 
(Campbell-Sills et al., 2013; Lehrer et al., 2008a; 2008b; Parry et al., 2012; Ross et al., 2005; 
Sommaruga et al., 1995). Three of the included trials provided minimum or no asthma-related 
education (Campbell-Sills et al., 2013; Hockemeyer & Smyth, 2002; Spurgeon et al., 2005). 
Two of the trials were rated lower regarding the suitability of the protocol for improving 
anxiety outcomes, as they mainly focused on improving asthma knowledge or  management 
and addressing asthma health perceptions (Put et al., 2003; Spurgeon et al., 2005). Of the 10 
trials, four were highly rated regarding the level of CBT input provided and the suitability of 
the protocol in improving anxiety (Lehrer et al., 2008a; 2008b; Parry et al., 2012; Ross et al., 
2005), and two were only adequately rated for offering brief or low intensity CBT input for 
anxiety complicated by asthma (Campbell-Sills et al., 2013; Sommaruga et al., 1995).  
3.4.5. Key findings  
Seven out of 10 trials included in this review reported favourable results for the CBT 
intervention in terms of reducing anxiety (Lehrer et al., 2008a; 2008b; Maes & Schloser, 
1988; Parry et al., 2012; Ross et al., 2005; Sommaruga et al., 1995; Spurgeon et al., 2005), 
with these benefits largely maintained at follow-up.  
Of the three studies whose overall methodology was best suited to address the review 
question, two found that CBT reduced anxiety relative to controls (Parry et al., 2012; Ross et 
al., 2005), whereas Campbell-Sills and colleagues (2013) found no significant differences 
between treatment as usual and computer-assisted CBT. This difference may be due to the 
lack of asthma-related input in their intervention or the lower intensity of the computerised 
CBT provided, which may have been insufficient to enable improvements for anxiety 
complicated by asthma; especially as mental health comorbidity was not excluded in this 




study. In addition, the treatment groups’ demographic data and baseline clinical 
characteristics in this study were not reported (Campbell-Sills et al., 2013), thus hindering the 
evaluation of potential bias in allocation between trial arms, which may also explain this 
outcome. 
Intervention integrity was also a significant limitation in the additional two studies, which 
reported no favourable results for CBT for anxiety (Hockemeyer & Smyth, 2002; Put et al., 
2003). Put and colleagues (2003) only aimed to improve anxiety as a secondary goal, such 
that their protocol was primarily focused on using CBT to change illness-specific perceptions 
(self-monitoring for asthma-related stimuli, modifying irrational cognitions about asthma and 
asthma therapy). This protocol may not be expected to change generalised anxiety or panic 
disorder outcomes, which are the most frequent anxiety co-morbidities in the context asthma 
(Goodwin et al., 2003). Hockemeyer and Smyth (2002), focused on improving anxiety 
outcomes, but provided a low intensity 4-week workbook intervention without therapist 
input, which may be less sufficient for managing anxiety complicated by asthma. Perhaps, 
more importantly in this trial the post-evaluation instructions referred to the treatment period 
- rather than the post-treatment period, during which anxiety would be expected to be similar 
to baseline or elevated; results, therefore, did not accurately reflect post-treatment 
effectiveness. 
Interestingly, two of the three trials providing minimum or no asthma-related education 
(Campbell-Sills et al., 2013; Hockemeyer & Smyth, 2002) found no significant differences 
on anxiety between the experimental groups, suggesting that asthma-related education may 
be important in enabling reductions in anxiety complicated by asthma. Studies with greater 
methodological rigour would be required to confirm this. Spurgeon and colleagues (2005) 
although not providing asthma-specific education, still included health-related input in their 




protocol, which may account for the positive effects of CBT on anxiety in their study. 
3.5. Children and young people 
3.5.1. Study design 
Four trials involving children or adolescent participants met criteria for inclusion in this 
systematic review, of which only one was an RCT (Colland, 1993), one was a non-
randomised controlled trial (Papneja & Manassis, 2006), and two utilised repeated-measures 
designs (Long et al., 2011; Marriage & Henderson, 2012). The evidence from the later two 
was rated as significantly more limited, in relation to the RCT and controlled trial, which 
were rated as providing similarly strong evidence in relation to the review question (Table 3). 
3.5.2. Sample representativeness and power 
The age of participants ranged between 7 to 14.2 years, with sample sizes for the intervention 
condition of between 17 and 48 participants (Table 2). Aside from Marriage and Henderson 
(2012), all other studies had relatively low attrition rates (0%-20%) for the treatment group 
and adopted suitable analyses in relation to addressing the review question. The first author 
computed a post-hoc power analysis for the pre-post results of the intervention group of each 
trial using the G*power programme. Colland (1993) and Papneja and Manassis (2006) were 
rated high for achieving a power of at least 0.8 estimating effect size to be medium and using 
an alpha of 0.05.  
Recruitment methods and eligibility criteria varied substantially between studies. Despite the 
overall high rating, sample representativeness in Colland (1993) was only adequately 
addressed because of recruitment criteria evaluating coping skills rather than anxiety 
symptomatology. Long and colleagues (2011) utilised a representative respiratory sample, but 
did not assess clinical need to undergo an anxiety intervention at the recruitment stage. In 




contrast, Marriage & Henderson (2012) included clinically relevant participants that had both 
asthma and anxiety symptoms, although representativeness was limited by unclear screening 
methods for anxiety and recruitment from a single respiratory clinic. Papneja and Manassis 
(2006) utilised data from a large scale anxiety RCT, analysing data for participants with co-
morbid anxiety and asthma and was, thus, rated higher on this criterion.  
3.5.3. Outcome measures  
All studies on younger participants used primary anxiety measures that were well-validated 
and reliable (SCAS; Spence, 1998, RCMAS; Reynolds & Richmond, 1985 and STAIC; 
Spielberger, Edwards, Lushene, Montuori, & Platzek, 1973). Two studies assessed the 
outcomes of the intervention up to 6 and 12 months later (Table 2). 
3.5.4. Interventions 
Two trials examined CBT in group formats and one in individual format (Table 2). One study 
provided the intervention in both formats, but reported their combined results, due to their 
outcomes not being significantly different between conditions (Papneja & Manassis, 2006). 
Half of the trials involved some level of participation of significant others in treatment 
(Colland, 1993; Papneja & Manassis, 2006). The number of offered sessions ranged between 
6 and 12. All interventions were facilitated by therapists of varied training and experience, 
from psychologists, psychiatrists and psychotherapists (Colland, 1993; Papneja & Manassis, 
2006) to graduate therapists, MSc clinicians or research assistants (Long et al., 2011), and a 
respiratory nurse (Marriage & Henderson, 2012). Only one study recorded sessions and rated 
them independently to ensure adherence to treatment protocol (Papneja & Manassis, 2006).  
Three studies (Long et al., 2011; Marriage & Henderson, 2012; Papneja & Manassis, 2006) 
were designed to reduce anxiety as one of their primary aims. Two of the trials were rated 




lower on the treatment suitability for improving anxiety outcomes, as their protocol content 
focused mainly on improving asthma knowledge and perceptions (Colland, 1993; Long et al., 
2011). Papneja & Manassis (2006) was the only trial not providing asthma-related education.  
3.5.5. Key findings  
All four trials reported significant reductions in the general anxiety outcomes following a 
CBT intervention on children with asthma, which were maintained at the follow-up 
evaluations. Of the two methodologically stronger studies, Colland (1993) found that asthma 
training and CBT led to significantly greater improvements in anxiety compared to a single 
information session for families or to no treatment. Papneja and Manassis (2006) compared 
the relative effectiveness of a CBT intervention protocol for anxious children with and 
without asthma. A statistically significant improvement in general anxiety scores across time 
was found for the anxious group with asthma, but the intervention was slightly less effective 
amongst children in this group as compared to anxious controls without asthma. In addition, 
the physiological anxiety subscale scores actually slightly increased at post-treatment for the 
co-morbid asthma and anxiety group, but not for the anxious controls without asthma. 
Several reasons may account for this, including the increased complexity of the experimental 
group and the absence of input regarding asthma in a group that is likely to additionally 
experience asthma-related anxiety complications.  
Interestingly, Colland (1993) found favourable anxiety outcomes after their CBT 
intervention, despite having been rated poorly on the suitability of the applied protocol for 
improving anxiety due to mainly focusing on asthma knowledge and management. Closer 
examination shows, however, that only the asthma-specific, as opposed to the general, 
anxiety results were maintained at the six and 12 month follow-up. Long and colleagues 
(2011), also found mixed results with no improvement on one of the primary anxiety 




inventories (STAIC), but limited conclusions can be drawn given that the sample was not 
selected to be clinically anxious, and the intervention protocol or therapists’ experience were 
only adequately appropriate to improve anxiety outcomes.  
4. Discussion 
This systematic review aimed to explore the effectiveness of CBT interventions for anxiety in 
individuals with co-morbid asthma and anxiety. The 14 reviewed trials presented reasonable 
preliminary evidence to support the use of CBT for anxiety in the context of asthma both for 
adults and for children/young people (7-14 years).  
The intervention protocol appeared important in addressing the review question. The majority 
of reviewed studies used a generic CBT approach, with some focusing on modifying health 
perceptions and asthma knowledge as a way to reduce anxiety in the context of asthma, rather 
than applying a specific empirically-validated CBT model for anxiety disorders (e.g., for 
panic or health anxiety; Clark, 1986; Warwick & Salkovskis, 1990). In the six studies where 
ratings suggested that a suitable treatment protocol was used to improve anxiety outcomes, 
the findings indicated CBT as an effective treatment.  
Prevalence studies highlight the increased comorbidity of panic, generalised anxiety disorder 
or even social anxiety amongst individuals with asthma (Goodwin et al., 2003; Hasler et al., 
2005; Vila et al., 2000). Some of the reviewed trials successfully used a panic/health anxiety 
focus in their CBT intervention (e.g., Parry et al., 2012; Ross et al., 2005). Although health 
anxiety is less frequently cited in literature as an asthma complication, this is likely to be due 
to most prevalence studies not administering measures designed to identify health anxiety. 
More recently, this field has shifted towards adapting anxiety CBT models for asthma and 
exploring cognitions, which may maintain the high comorbidity between asthma and anxiety 
(De Peuter et al., 2008; Deshmukh, Toelle, Usherwood, O'Grady, & Jenkins, 2007). This shift 




may be further validated by evidence in this review showing that interventions which 
provided minimum or no asthma-related input found no significant differences on anxiety 
between the experimental groups (Campbell-Sills et al., 2013; Hockemeyer & Smyth, 2002), 
or were only partially successful in improving anxiety, with levels of physiological anxiety 
remaining high at post-treatment (Papneja & Manassis, 2006).  
Another factor important in addressing the review question was the clinical relevance of the 
samples. Only half of the reviewed studies screened for anxiety as part of their eligibility 
criteria. In studies where the recruitment method and inclusion criteria were rated higher to 
indicate a clinically representative anxious sample with asthma the results favoured the use of 
CBT for anxiety. 
4.1. Limitations of reviewed articles and future research 
Many of the included studies did not have control groups, with the remaining studies usually 
having only non-active groups (e.g. waitlist or standard asthma care). Future studies may 
consider comparing CBT with other psychological therapies. 
Significant heterogeneity existed between the applied outcome measures, limiting potential 
for comparisons between studies in the current review. Comparisons were also limited as a 
result of the substantial diversity between the CBT protocols employed, many of which 
primarily focused on modification of asthma behaviours or knowledge as means to reduce 
anxiety rather than directly on specific anxiety beliefs. The present review aimed to include 
all CBT studies targeting anxiety as an outcome in an asthma sample, which subsequently 
revealed the importance of the intervention rationale and content. To increase effectiveness 
perhaps future trials need to consider more thoroughly tailoring the treatment protocol, using 
existing evidence regarding this comorbidity and the mechanisms that may maintain it.    




Future studies would also benefit from giving greater consideration to protocol adherence and 
the training of therapists as these aspects of methodology were often not well addressed in the 
reviewed studies, despite having consistently been found to impact on psychotherapy 
research findings (Huppert et al., 2001; Rakovshik & McManus, 2010).  
Sample representativeness was of variable quality across studies, with most employing small 
samples that would not enable sufficient power for analyses. In half of the reviewed studies, 
anxiety was not a criterion for inclusion, but was assumed, e.g., by the medication overuse. 
This is likely to impact on the outcomes and effect sizes, as inclusion of individuals without 
anxiety naturally reduces the potential to deliver reductions in anxiety. Attrition rates were 
also significant amongst studies, reaching up to 50%; although they were lower in most 
studies involving children and adolescents, potentially due to parental involvement in 
supporting attendance. Of the trials that had attritions, with the exception of two, others did 
not consider how to manage missing data in the analysis, which may increase bias in the final 
conclusions (Azar, 2002).   
4.2. Implications for clinical practice and policy  
The complications of the interplay between asthma and anxiety have extensively been 
discussed in the literature (Lehrer et al., 2002), including overperception of asthma symptoms 
and overreaction during episodes (De Peuter et al., 2008; Main et al., 2003), overuse of 
reliever medications and increased healthcare use, independently of pulmonary function (De 
Peuter et al., 2005; Feldman et al., 2009; 2005) or asthma severity (Rietvield et al., 2005), 
unnecessary hospital admissions and pharmacological prescriptions (Fernandes et al., 2010), 
and enormous costs for the healthcare providers (Hutter et al., 2011; Jones et al., 2008). 
Strategic planning reports and national guidelines (DoH, 2011; 2014; Scottish Government, 
2012; SIGN, 2012a) have long called for appropriate interventions to manage this co-




morbidity, whilst highlighting that evidence is inconclusive.  
The current systematic review endeavoured to delineate the outcomes of diverse and 
inconclusive research in this field (Yorke et al., 2009a; 2009b) by solely focusing on anxiety, 
given that it is the most common mental health comorbidity of asthma (Hasler et al., 2005) 
and on CBT interventions only, given that it comprises the treatment of choice for anxiety in 
general (NICE, 2011; Scottish Government, 2011) and in other respiratory conditions 
(Livermore et al., 2010). In such a framework, findings become less inconsistent and inform 
clinical practice by offering some preliminary support for the use of an anxiety-focused 
model combining cognitive and behavioural interventions, potentially including asthma-
related input. Future guidance about the usefulness of psychological interventions in the 
context of asthma may, thus, benefit from closely defining targeted outcomes (asthma 
management or anxiety) and thus interventions and reflect more fully on issues of clinical 
representativeness in an attempt to facilitate greater clarity.  
4.3. Strengths and limitations of review 
This systematic review benefits from the use of quality criteria purposefully developed to 
address this review question. Existing quality criteria (e.g., SIGN, 2012b) were consulted, but 
needed adaptation. This was mainly due to the methodological variation between the 
reviewed studies, including non-randomised controlled trials or observational studies, in 
addition to the heterogeneity of the treatment protocols, the participants’ clinical 
characteristics and comparators. All of these factors required specifically operationalised 
criteria to address them and ensure high consistency between raters. However, limitations 
may be identified in relation to the quality rating system. As criteria were not truly equally 
weighted, differentially rating them could potentially be considered fairer. Similarly the 
numerical cut-offs for the quality characterisation of studies from poorly to well-addressed 




may be viewed as arbitrary. 
The included studies were published in peer-reviewed journals, which may lead to 
publication bias. Efforts to address this were conducted by contacting key authors, and 
searches in the web or in citations of included papers for unpublished documents, conference 
presentations or dissertations. Due to limited resources search was restricted to work in 
English. Specific and closely defined search terms were employed and three major databases 
were only explored, all of which could potentially omit further eligible trials. Multiple 
manual searches in relevant journals and references were employed to mitigate such 
limitations.  
4.4. Conclusions  
The current systematic review offers some positive preliminary evidence for the effectiveness 
of CBT in reducing anxiety amongst adults and children/young people with asthma. The 
overall quality of reviewed studies was moderate and further methodologically robust studies 
evaluating CBT interventions that are specifically tailored to treat anxiety in the context of 
asthma are necessary. 
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Empirical study hypothesis and aims 
There is a well-established link between asthma and anxiety, leading to exacerbations for 
both conditions. The preceding systematic review summarised the evidence regarding the 
effectiveness of cognitive-behavioural therapy (CBT) in improving anxiety in adults and/or 
children with asthma. The reviewed papers presented reasonable preliminary support for the 
use of CBT for anxiety in the context of asthma across the age range. However, the overall 
trial quality was moderate, calling for more methodologically robust research.  The rationale 
and content of the intervention protocol appeared critically important in determining the 
effectiveness of CBT for anxiety in the context of asthma. Consistent with other work in this 
field (Deshmukh et al., 2007; Nardi, 2005; Papneja & Manassis, 2006), the systematic review 
highlighted the importance of adapting anxiety treatment protocols and designing tailored 
interventions to the needs of this specific population. To tailor interventions to the needs of a 
particular population, however, it is first necessary to understand the perceptions and 
subjective experiences of the people in question.  
The following empirical study seeks to investigate the interplay between childhood asthma 
and anxiety from the perspective of children and adolescents through in-depth semi-
structured interviews. Qualitative data may shed light on the mechanisms that link these 
factors and may perpetuate this strong comorbidity, e.g., the attributions young people make 
regarding the experience of this relationship, problem-solving processes during symptom 
confusion and unhelpful management strategies. The findings are expected to inform clinical 
assessments, contribute to the development of a conceptual model and in the adaptation of 
psychological interventions.  
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Qualitative research evaluative criteria (Yardley, 2000) and interpretative phenomenological 
analysis (IPA) quality assessment recommendations (Smith, 2011) were followed to ensure 
credibility and rigour in the following empirical study. Within this framework, a clear audit 
trail of each stage of the analysis and the pathway that led to the final report was kept. A 
reflective log prior to and throughout the process, demonstrating thoughts, decisions, prior 
expectations and consideration of potential bias further promoted reflexivity and 
transparency. This reflective prologue aims to elucidate some of this process, outlining the 
study context and the researcher’s role, experience and prior expectations to enable the 
consideration of potential bias in the analysis and choice of data for presentation.  
Characteristics of the research context 
This study was undertaken within an NHS paediatric psychology service operating in close 
(physical and organisational) proximity to the medical teams that initiate most of its referrals, 
including the paediatric asthma service. Three specialist respiratory teams in equivalent NHS 
Boards were approached and two participated in the study allowing access to their patient 
database. As with other common physical health conditions, the tertiary services involved 
tend to follow up the most complex cases, which for multiple reasons may not be suitable for 
monitoring in the community. These services are based within urban hospitals, cover wide 
geographical regions and follow up children and adolescents aged 0-16 years. The specialist 
asthma nurses facilitating the contact with the potential participants are in close and regular 
contact with the families. Within this context, the involvement of the asthma treatment team 
in the present research by initially inviting potential participants to support the study and the 
interview venues in clinical health settings were likely to have influenced the information 
respondents chose to share, despite having been informed that their participation would 




remain anonymous to the respiratory specialists. 
Characteristics of the researcher 
As this section focuses on the personal reflections of the main researcher regarding the 
influence of their role and prior conceptions on the findings, it is written in the first person.  
I previously worked as a child and adolescent therapist in a paediatric 
psychology and neuropsychology service for 2½ years. Within this role, I was 
exposed to the impact and potential sequelae of chronic physical health 
conditions, including respiratory conditions, on children and young people. 
This experience shaped my interest in paediatric clinical health and I thus 
looked to develop a thesis within this field when undertaking my doctoral 
training in clinical psychology. Liaison with my subsequent field research 
supervisor drew my attention to anxiety in the context of asthma and the 
increased number of referrals the service receives about reliever medication 
overuse.  
I consequently researched this area further and my interest was fuelled when 
discovering that, unlike my initial hypothesis, hyperventilation is only one of 
the multiple factors that are significant in the interplay between asthma and 
anxiety. It was also intriguing to discover that despite the availability of 
effective treatments for anxiety in general, these appear neither suitable nor 
particularly successful in the context of asthma. This exploration naturally led 
to the formulation of this thesis aims regarding evaluating available treatment 
programmes for anxiety amongst individuals with asthma and exploring the 
mechanisms that maintain the comorbidity from the perspective of young 
people, to allow an empirically supported adaptation of psychological 




interventions and improve their effectiveness.  
Aware of my prior clinical experience in working with young people with 
asthma, the service’s high rates of referrals for asthma reliever medication 
overuse and my developing knowledge of research findings in this field, I kept 
a reflective log to report my pre-conceptions and own attributions so as to 
promote transparency in the interpretation of the findings.  This included my 
expectation that a large part of the participants’ narratives would focus on 
anxiety-induced hyperventilation, confusing symptoms with asthma and 
responding by inappropriately using medication. It further included reflections 
on the influence of my expectation and study objective to use the qualitative 
outcomes to adapt psychological interventions and self-help material, which 
were likely to have a cognitive-behavioural treatment (CBT) perspective due to 
this modality appearing more effective in managing anxiety without physical 
health co-morbidities. Indeed, upon reflection this influenced even the design 
of the interview schedule used, directing questions in such manner that would 
allow the surfacing of participant’s thoughts, feelings, bodily responses and 
coping behaviours. Being aware of this predisposition, but also my knowledge 
in psychological theory, when analysing the transcripts I was mindful that I 
would be more likely to recognise cognitive-behavioural mechanisms known to 
maintain anxiety, such as avoidance, which may have been less likely to have 
been picked out by other professionals, should they have conducted the 
analysis. This may be viewed as a limitation, but it may also be one example of 
why in IPA the researchers’ existing knowledge and prior experience could 
potentially be a strength and is considered integral within the double 
hermeneutic process.  




However, to reduce the effects of confirmation bias I purposefully tried to look 
for patterns that could have fitted in different modalities or disproved such 
interpretations of the findings. Additionally, I thoroughly discussed such 
predispositions in supervision, as a novel qualitative researcher, and actively 
looked to increase the credibility of the findings by having transcripts second-
coded and interpretations validated by respondents and other important 
stakeholders (e.g., parents, nurse specialists).  
Within this log, I also reflected on my own worries regarding interviewing 
children and adolescents and how this may influence the process. From my 
clinical background, I was aware of the difficulties this age group may have in 
verbalising their experiences, but also the challenges in engaging them at 
times. Such worries account for the development of an interview guide that 
included prompts about areas adolescents may wish to consider. This was also 
consistent with recommendations about interviewing younger aged 
participants.  
Finally, my anxiety about undertaking qualitative research with limited prior 
experience in this methodology covered a significant part of my reflections. To 
increase my confidence, I closely followed IPA guide books and quality 
measures and constantly tried to gain an understanding of the rationale behind 
each recommended step of the analysis, in addition to utilising supervision.  
This brief prologue regarding the first author’s predispositions aimed to promote transparency 
and allow the reader to evaluate bias in the research process, analysis and presentation. 
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The current study examined the lived experience of childhood asthma and anxiety directly 
from the affected population, to explore the specific thinking and behaviour patterns 
maintaining this strong comorbidity. Interpretative phenomenological analysis (IPA) was 
used to analyse eleven in-depth semi-structured interviews with young people (aged 11-15) 
living with the comorbidity. Well-established qualitative research recommendations were 
followed to promote credibility and rigour in the findings. Three super-ordinate themes 
emerged: i) the influence of asthma by inhibiting coping activities or developmental tasks, 
triggering catastrophic thinking and leading to an over-generalisation of asthma coping 
strategies to managing anxiety; ii) the influence of anxiety by affecting appropriate use of 
medication and triggering hyperventilation-induced asthma exacerbations; iii) the interaction 
between asthma and anxiety by forming an unhelpful positive feedback loop and triggering 
symptom confusion. The proposed mechanisms lend themselves to a cognitive-behavioural 
framework, potentially including mindfulness-based interventions, and may be used to tailor 
psychological treatments. 
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 The experience of asthma and anxiety was explored directly from the affected population 
 Eleven interviews with young people living with the comorbidity were analysed using IPA 
 Eight subthemes emerged outlining possible maintaining mechanisms for the comorbidity  
 The proposed subthemes can be used to adapt cognitive-behavioural interventions 
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Asthma is the most common chronic childhood condition (Goodwin, Ferguson, & Horwood, 
2004). It is estimated that over 1.1 million children in the UK suffer from asthma (National 
Institute for Health and Care Excellence [NICE], 2013), whilst worldwide prevalence rates 
range from 5.6% to 26.7% (Pearce et al., 2007).  
In recent years a large body of evidence has confirmed that individuals with asthma present 
with greater mental health comorbidity, notably anxiety, when compared to their general 
population counterparts or even with populations with other chronic health conditions, such 
as arthritis (Di Marco, Santus & Centanni, 2011). Childhood asthma is associated with a 
higher risk of experiencing any anxiety disorder, including separation anxiety, specific 
phobia, panic and generalised anxiety disorder (Gupta, Mitchell, Giuffre, & Crawford, 2001; 
Ortega, Huertas, Canino, Ramirez, & Rubio-Stipec, 2002). Vila and colleagues (2000) 
compared 82 children with moderate/severe asthma with matched healthy controls. They 
found that children with asthma were substantially more likely to experience anxiety, with a 
third of their asthma sample meeting criteria for an anxiety diagnosis, primarily generalised 
anxiety disorder (Vila, Nollet-Clemencon, de Blic, Mouren-Simeoni, & Scheinmann 2000). 
In a cross-sectional epidemiological study of 1285 youth (9-17 years) in the US, Goodwin, 
Pine and Hoven (2003b) showed that self-reported asthma was linked with a twofold higher 
risk of panic attacks (O.R.=2.2), even after controlling for demographic and psychological 
comorbidity factors.  
1.1. Understanding the mechanisms linking asthma and anxiety 
The mechanisms explaining this comorbidity are largely unclear, but it is currently widely 
acknowledged that there is an interplay between anxiety and asthma, leading to greater 
exacerbations for both conditions (Lehrer, Feldman, Giardino, Song, & Schmaling, 2002).  




Studies on the relationship between asthma and anxiety in children are scarce, but research on 
adult populations can be informative. Anxiety may exacerbate asthma symptoms by 
increasing hyperventilation, which may cause bronchoconstriction (Meuret & Ritz, 2010). 
The release of cytokines and neuropeptides during an anxiety episode may further exacerbate 
asthma by triggering airway inflammations and allergic reactions (Chiang, Ma, Huang, 
Tseng, & Hsueh, 2009; Frieri, 2003). Asthma attacks, in turn, can be particularly aversive, 
which may reinforce anticipatory anxiety and avoidance (Carr, 1998), and may increase 
health-related fear or hypervigilance regarding threatening bodily symptoms (Feldman, 
Siddique, Thompson, & Lehrer, 2005; Lehrer et al., 2008). Hypervigilance and selective 
attention on somatic symptoms are identified by predominant psychological models on panic 
and health anxiety as key factors for maintaining such difficulties (Clark, 1986; Warwick & 
Salkovskis, 1990). Interestingly, asthma illness severity, as measured by pulmonary tests, is 
not a significant predictor of anxiety symptoms (Rietvield, Van Beest, & Prins, 2005). 
Research has shown that individuals with asthma and anxiety tend to overperceive symptoms 
of asthma and overreact during asthma episodes (De Peuter,
 
Lemaigre, van Diest, & van den 
Bergh 2008; Main, Moss-Morris, Booth, Kaptein, & Kolbe, 2003). For example, Chen, 
Hermann, Rodgers, Oliver-Welker, & Strunk (2006), measured pulmonary function and 
subjective symptom perception in 86 children with asthma during a bronchial challenge test. 
They showed that children with increased anxiety at baseline reported greater asthma 
symptoms than suggested by the pulmonary function measures, especially when symptoms 
were mild or ambiguous (Chen et al., 2006). Studies with adults have confirmed that anxiety 
predicts overuse of medication and increased healthcare use, independently of objective 
pulmonary function (Feldman et al., 2009; Feldman, Lehrer, Borson, Hallstrand, & Siddique, 
2005). This results in enormous costs for the NHS due to unnecessary hospital admissions 
and increased primary care use, as well as an over-prescribing response from medical staff 




(Fernandes et al., 2010; Hutter, Knecht, & Baumeister, 2011; Jones et al., 2008). In relation 
to medication use, in particular, it has been shown that at least one third of asthma patients 
overuse their reliever medication independently of their lung function (Hand & Bradley, 
1996). Increased reliever inhaler use, however, has been linked with several medical 
complications, including cardiovascular symptoms (Newhouse et al., 1996) and tolerance 
effects (Taylor, Sears, & Cockroft, 1996), resulting in implications for their effectiveness.  
The interplay between anxiety and asthma is also complicated because of the overlap of 
symptoms creating confusion regarding the cause of symptoms (e.g., chest tightness versus 
throat tightness, shortness of breath versus hyperventilation) and, therefore, leading to 
inappropriate care in cases of misinterpretion (Lehrer, 1998; Schmaling & Bell, 1997). This 
may be more evident amongst children and young people who are developmentally less able 
to make such fine distinctions. In addition, the suggested management strategies for the two 
conditions alone are often contradictory (Lehrer et al., 2002). For example, although for panic 
and anxiety, distress tolerance and gradual habituation to the symptoms would be 
recommended (Carr, 1999); for asthma, increased sensitivity to symptoms is suggested and 
an appropriate level of anxiety about exacerbations is reinforced in order to trigger prompt 
action during an episode (Lehrer et al., 2002).  
The provision of effective anxiety treatments in the context of asthma is, therefore, of crucial 
importance. SIGN guidelines (Scottish Intercollegiate Guidelines Network, 2012), strategic 
planning and policy documents in the UK (Department of Health [DoH], 2011; 2014; 
Scottish Government, 2012) emphasise the significance of identifying anxiety early amongst 
individuals with respiratory conditions and developing suitable psychological interventions. 
1.2. Developing treatments for anxiety in the context of asthma 
Research initially turned to the development of asthma care programmes enhanced with 




psychological techniques to manage co-morbid anxiety; primarily relaxation and breathing 
retraining exercises. The outcomes of systematic reviews on such studies are contradictory 
(Freitas et al., 2013) with some reporting no significant results (Huntley, White, & Ernst, 
2002). Apart from the methodological differences amongst these studies, the inconclusive 
outcomes may be linked to some of such interventions solely targeting the physiological 
symptoms of anxiety, possibly hypothesising that this is the single mechanism linking asthma 
and anxiety. Respectively, other available treatments solely focus on some cognitive aspects 
of the interplay targeting health worries and aiming to change asthma illness perceptions only 
(Kaptein, Klok, Moss-Morris, & Brand, 2010), despite prevalence surveys indicating 
generalised anxiety and panic as the most frequent co-morbidities (Goodwin, Jacobi, & 
Thefeld, 2003a; Vila et al., 2000). Perhaps more importantly, the multifaceted nature of 
anxiety is not acknowledged in such programmes, involving cognitive, emotional, 
behavioural and bodily factors (Selingman, Walker, & Rosenhan, 2001) that need to be 
considered in a comprehensive model in order to promote long-term improvements.  
Cognitive-behavioural treatment (CBT) approaches would appear appropriate in this respect 
and have strong empirical support in treating anxiety without physical health comorbidities 
(NICE, 2011; Scottish Government, 2011). Nine controlled trials have been published 
examining the effectiveness of adapted CBT interventions in improving anxiety and asthma 
outcomes in adults (Campbell-Sills et al., 2013; Grover, Kumaraiah, Prasadrao, & D'Souza 
2007; Hockemeyer & Smyth, 2002; Maes & Schloser, 1988; Ross,
 
Davis, & MacDonalds, 
2005; Parry et al. 2012; Put, van den Bergh, Lemaigre, Demedts, & Verleden, 2003; 
Sommaruga et al., 1995; Spurgeon, Hicks, Barwell, Walton, & Spurgeon, 2005) and three in 
children and adolescents (Colland, 1993; Long et al., 2011; Papneja & Manassis, 2006). Their 
effectiveness ranged significantly, with some showing favourable findings, although they had 
considerable limitations, including: small N designs, high attrition rates, sampling limited to 




one respiratory centre or non-clinically anxious participants, and significant variations in the 
CBT protocols. Interestingly, the single controlled trial comparing 36 children and young 
people with asthma and anxiety with matched anxious controls without asthma (Papneja & 
Manassis, 2006) found less favourable results in the general anxiety scores of the co-morbid 
group in relation to the non-asthmatic group, whilst noting an increase in their physiological 
anxiety. This may point to the importance of using a treatment that is adapted to consider the 
unique impact of this comorbidity on the experience of physiological states.  
In addition, the poorer and inconsistent outcomes of the CBT interventions may be linked to 
our limited knowledge regarding the role of cognitive processes in maintaining this complex 
comorbidity (McLeish, Zvolensky, & Luberto, 2011), especially amongst children and 
adolescents. De Peuter and colleagues (2008) attempted to shed light on the role of 
catastrophic thinking in perpetuating anxiety in adult asthma by directly adapting the ‘Pain 
Catastrophizing Scale’ (Sullivan, Bishop, & Pivik, 1995) to the symptoms of asthma. Using 
this scale they found that catastrophic thinking predicted asthma symptom overperception in 
72 adult patients both during asthma exacerbations and in general (De Peuter et al., 2008). 
Main and colleagues (2003) also used a mediation model to show that negative affect may 
lead to a misinterpretation of non-specific symptoms as symptoms of asthma, which may 
subsequently trigger symptom overperception and medication overuse.  
McGrady and colleagues (2010) in their sample of 151 urban adolescents found that 
perceiving asthma as difficult to control and as significantly affecting life, mediated the 
relationship between asthma and anxiety. However, research to explore such cognitive 
vulnerabilities in young people is extremely limited, and generalising evidence from adult 
studies may fail to take into account developmental or family factors. In addition, no study to 
date has explored such cognitive processes directly from the perspective of children and 




adolescents in order to extrapolate the specific unhelpful thinking and behavioural patterns 
that maintain their difficulties. Qualitative approaches would provide valuable information in 
this respect. For example, qualitative data on treatment adherence indicate that medication 
may be used as a safety-seeking strategy, e.g., “I always walk with my spray. If I discover I 
don’t have my pump...you could feel the tightness, and I jump off the bus and go back home” 
(p. 411; in Choi, Westermann, Sayles, Mancuso, & Charlson, 2008).  
1.3. Study aims 
Several papers have highlighted the urgent need to design tailored interventions and adapt 
standard CBT protocols for the needs of this population (Deshmukh, Toelle, Usherwood, 
O'Grady, & Jenkins, 2007; Nardi, 2005; Papneja & Manassis, 2006). This may be particularly 
important in childhood asthma where evidence regarding effective treatments is limited and 
multiple factors, such as the role of significant others and developmental issues have not been 
explored (Vuillermin et al., 2010). To tailor interventions to the needs of a particular 
population, however, it is first necessary to understand the perceptions and subjective 
experiences of the people in question.  
The current study seeks to investigate the interplay between asthma and anxiety from the 
perspective of children and adolescents. Qualitative data may shed light on the mechanisms 
that link these factors and maintain this comorbidity, e.g., the attributions young people make 
regarding the experience of this relationship, problem-solving processes during symptom 
confusion, unhelpful management strategies.  
2. Method 
2.1. Study design   
Interpretative phenomenological analysis (IPA) was used to analyse 11 in-depth semi-




structured interviews with children and adolescents, who had both asthma and anxiety 
symptomatology. IPA is concerned with how individuals perceive their world and reflect on 
their lived experience (Smith & Osborn, 2003). It involves the individuals’ attempt to make 
sense of their experience and the researcher’s effort to make sense of the individuals’ 
accounts, filtering them through their own perceptions, experiences and pre-existing beliefs 
(Smith, Flowers, & Larkin, 2009; Starks & Trinidad, 2007). In recent years, IPA has become 
the approach of choice in qualitative healthcare research (Reid, Flowers, & Larkin, 2005). It 
has been extensively used to derive service users’ experiences of conditions or treatments and 
has substantially contributed in a number of areas, including genetics (Michie, Smith, Senior, 
& Marteau, 2003), cancer (Jarrett, Payne, Turner, & Hillier, 1999) and pain (Osborn & 
Smith, 1998). It benefits by its compatibility with current psychological models, such as 
CBT, as within its theoretical framework it assumes a connection between participants’ talks, 
thoughts and affect (Smith & Osborn, 2003). It was, therefore, considered appropriate to 
address the current study objectives (see extended method chapter for details).   
2.2. Research ethics review 
Approvals were obtained from the NHS Research Ethics Service and the local Boards’ 
Research and Development offices (Appendix C). Approved procedures were undertaken to 
secure anonymity and confidentiality of the initial data and interviews and to remove 
identifiable data from the transcripts. Issues regarding safeguarding participants’ well-being 
and preventing distress were carefully considered. Participation was voluntary and 
confidential from the respiratory teams, informed consent and parental assent were obtained. 
2.3. Recruitment  
Consistent with IPA’s idiographic approach, the sampling focused on recruiting a closely 
specified homogeneous group of young people for whom the research question was most 




pertinent (Gavin, 2008), to allow for a clinically relevant in-depth case-by-case analysis 
(Smith & Osborn, 2003). To reduce bias in the selection of potential participants at the initial 
recruitment stage, a random sampling procedure was used. This ensured the approach of 
potential respondents that may have not been picked out by respiratory specialists; especially 
given the poor attendance rates in adolescent asthma clinics. 
A consecutive series of 231 children and adolescents (aged 11-16) with a diagnosis of 
asthma, in accordance with the British Thoracic Society/Scottish Intercollegiate Guidelines 
Network (2008), were randomly-selected (using random.org) from the tertiary childhood 
asthma databases in NHS Lanarkshire and NHS Lothian and invited to participate in the 
study by post (see Appendix D). Thirty three (14.28%) returned completed their contact 
details and the screening information forms, including: a) a purposefully-designed form with 
questions exploring eligibility criteria, namely an asthma diagnosis of at least six months, 
fluency in English and no other mental health, learning, developmental or physical health 
condition (apart from asthma-related/atopic disorders, which are highly co-morbid) and b) the 
Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999) to 
identify participants at high risk for anxiety.  
In line with findings suggesting that children with asthma are at substantially higher risk of 
experiencing any anxiety disorder (Gupta et al., 2001; Ortega et al., 2002), a general measure 
of anxiety was selected. The SCARED is a self-reported 41-item measure, consisting of five 
subscales: panic disorder/significant somatic symptoms, generalised anxiety, separation 
anxiety, social anxiety and school anxiety (Verhulst & van der Ende, 2006). It has been 
shown to have satisfactory psychometric properties, including high test-retest and internal 
reliability (alpha co-efficient of 0.90) and good validity (Verhulst & van der Ende, 2006). For 
the current research, the recommended cut-off score of 22 or above was used (Desousa, 




Salum, Isolan, & Manfro, 2013) to screen for participants that have increased anxiety 
symptoms.  
2.4. Participant characteristics 
Eleven respondents met inclusion criteria and all agreed to be interviewed. Participant 
characteristics are shown in Table 1. Names were replaced with pseudonyms to protect 
confidentiality and identifiable information was removed.   
 
Table 1. Participant characteristics 













separation anxiety (5/5), 
 school avoidance (4/3) 




generalised anxiety (9/9),  
separation anxiety (6/5) 
Liz F 11-13 
moderate 
 (≤ 7years) 
22 generalised anxiety (11/9) 




panic/somatic symptoms (8/7), 
separation anxiety (7/5) 




generalised anxiety (10/9),  
school avoidance (7/3) 




panic/somatic symptoms (7/7), 
generalised anxiety (11/9) 




panic/somatic symptoms (12/7), 
generalised anxiety (17/9),  
school avoidance (3/3) 




generalised anxiety (10/9), 
 social anxiety (8/8),  
school avoidance (3/3) 




panic/somatic symptoms (10/7), 
generalised anxiety (13/9), separation 
anxiety (6/5), social anxiety (8/8), 
school avoidance (3/3) 




panic/somatic symptoms (7/7), 
generalised anxiety (13/9) 




panic/somatic symptoms (14/7), 
generalised anxiety (143/9), 
separation anxiety (10/5), social 
anxiety (10/8), school avoidance (4/3) 
                                                          
 
3
 Participants’ scores on SCARED subscales on which they performed above the clinical cut-off as determined 
by the inventory’s authors (Birmaher et al., 1999). 




The mean age of participants was 13.09 years (SD = 1.37, range: 11-15). Seven were male 
(63.6%) and four female (36.4%). The majority of participants described their asthma as 
moderate at the point of the interview (on a 3-point self-report scale from mild to severe), 
with mean illness duration of 8.54 years (SD = 2.84, range: 2-12). The mean score on the 
SCARED was significantly above the clinical cut-off (M = 32.27, SD = 8.86). The SCARED 
subscales on which respondents scored in the clinical range as determined by the inventory’s 
authors (Birmaher et al., 1999) are also presented to demonstrate the types of increased 
anxiety symptoms participants within this sample reported. 
2.5. Data collection 
Nine of the interviews took place in community child and adolescent mental health services, 
one in a medical practice and one in a hospital clinic. All interviews were conducted by the 
lead author, a female clinical psychology doctoral trainee with pre-existing experience in 
paediatric clinical health. They were audio-recorded and duration ranged between 27 and 35 
minutes. The interviews were semi-structured, guided by a schedule (Table 2; extended 
version in Appendix H), which was developed to explore the experiences of living with 
asthma and anxiety, with probes relevant to empirical findings about this relationship. The 
schedule was piloted with three adults with childhood onset asthma using retrospective 
cognitive interviewing techniques (Haeger, Lambert, Kinzie, & Gieser, 2012; Willis, 1999).  
In line with the research aims, particular attention was paid to examining all aspects of the 
experience of the asthma and anxiety interplay, including cognitions, personal attributions, 
emotions, physiological reactions, coping behaviours and management strategies. IPA 
principles (Smith & Eatough, 2007) guided the development of the schedule, with open-
ended non-directive questions comprising the skeleton of the interview, whilst ensuring 
prompts were available to respond to potential developmental limitations in verbalising or 




recalling for the young participants (Docherty & Sandelowski, 1999) (see extended method 
chapter for detail).  
 
Table 2. Interview guide  
Interview guide 
Experience of asthma and anxiety separately 
Can you talk to me about what is asthma like for you?  
What has it meant for your life? 
Can you talk to me about what is anxiety like for you? 
What has it meant for your life? 
Relationship between anxiety and asthma 
Do asthma and anxiety influence or affect one another?  
When are they more likely to influence one another/occur together?  
How do you cope when asthma and anxiety influence one another /occur together?  
What sort of worries do you have about your asthma? 
How does worrying feel on your body; how is that different from an asthma attack?  
How do you know when to get your medication?  
 
2.6. Analysis   
In line with IPA guidance regarding the process of analysis, the verbatim transcription of the 
interviews commenced after all interviews were completed (Smith & Osborn, 2003). As the 
focus in IPA heavily relies on the researcher’s interpretative engagement with the 
participants’ accounts, the lead author’s previous experience, knowledge and expectations 
were logged a priori in a reflexive and open manner, not necessarily with the aim to withhold 
them, but rather to increase awareness of how these may influence the hermeneutic process.  
The analysis was led by the first author and followed the stages described in Smith and 
colleagues (2009). The individual transcripts were read repeatedly, twice alongside the audio-
recordings to encourage immersion with the data and sustain focus on each interview in its 




own merits, in keeping with IPA’s idiographic aspect. Descriptive, language and conceptual 
notes were made on the right-hand margin and these were subsequently overviewed to 
identify recurrent or particularly emotive points, associations and contradictions and allow 
the development of emerging themes within each interview (see Appendix K for an example 
of the initial coding). This process was repeated across all transcripts. When new themes 
emerged, previous interviews were re-visited to examine if such interpretations would be 
relevant.  
All elicited themes from each participant were organised into multiple tables in a single 
document to allow examination of patterns across cases and themes that could be clustered 
together. Principles of abstraction, polarisation, contextualisation, numeration and function 
guided the grouping of emergent themes into subordinate themes (Smith et al., 2009). 
Particular attention was paid to analysis negotiating both convergence and divergence, thus 
pointing to how participants displayed the same theme in their individual ways (Smith, 2011). 
In keeping with IPA methodology, when the same themes appeared in at least one third of the 
participants (4/11) they were considered recurrent. These themes were subsequently 
integrated to establish super-ordinate themes and a table of ‘master themes’ with supporting 
extracts from each participant was created.  
 2.7. Quality assurance 
Qualitative research evaluative criteria (Yardley, 2000; 2008) and IPA quality assessment 
recommendations (Smith, 2011) were considered to promote credibility and rigour in the 
present analysis. A clear audit trail of each stage of the analysis and the pathway that led to 
the final report was kept. A reflective log prior to and throughout the process, demonstrating 
thoughts, decisions, prior expectations and consideration of potential bias further promoted 
reflexivity and transparency. Homogeneous sampling and measures of subordinate theme 




prevalence were utilised. Multiple sources were used to validate the findings, including 
drawing on multiple theoretical perspectives to interpret the data, and inviting important 
stakeholders (i.e., respiratory specialists and parents) to cross-check a summary of the initial 
findings and refine explanations. To assist in this process, respondent validation was also 
attained with over half of the participants (6/11) commenting on the initial interpretation of 
the findings. Feedback from important stakeholders and respondents was incorporated in the 
final analysis where appropriate (see extended method chapter). A random selection of three 
transcripts was independently coded by the second author, who is experienced in IPA 
methodology. High level of agreement was found in the emergent themes (87%, 70% and 
81% of themes identified by the second rater in each interview respectively, were also noted 
by first author) and close supervision was utilised to reach consensus in the interpretation and 
development of master themes.  
3. Results 
The analysis produced three super-ordinate themes pertinent to the research question 
regarding how the mechanisms linking asthma and anxiety are perceived by young people. 
Participants described experiences of this comorbidity as a single directional relationship of 
one condition influencing the other, with fewer also discussing experiences of asthma and 
anxiety in patterns of interaction. Table 3 presents an overview of the themes revealed 
through the analysis and interpretation of the data and their prevalence across participants 
(see Appendix J for details). The extracts were selected based on their ability to present how 
themes could be manifested in brief, coherent, and meaningful ways (Smith, 2011).  
3.1. The influence of asthma   
The influence of asthma on participants’ experience of anxiety was evident across everyone’s 
accounts and appeared to have affected all aspects of their functioning, including 




developmental milestones, cognitions, behaviours and coping strategies.   
 








of asthma  
Asthma as a threat to important developmental goals 10 
Asthma as a barrier to valued, potentially coping, activities 11 
Asthma triggers worries and anxiety-provoking thinking patterns 11 
Strategies to manage asthma over-generalise to managing anxiety  9 
The influence 
of anxiety  
Physical symptoms of anxiety and anxiety-related behaviours trigger asthma  6 





Asthma and anxiety interact forming a positive feedback loop 5 
Confusion between symptoms of asthma and symptoms of anxiety 4 
 
3.1.1. Asthma as a threat to important developmental goals 
Ten participants referred to the impact of asthma on their efforts to achieve important 
developmental goals, such as making friendships, forming an identity and seeking autonomy. 
Purposeful homogeneous sampling meant respondents were in early or middle adolescence 
and all but one spoke of their continuous efforts to minimise the consequences of asthma on 
their developmental goals or negotiate a balance between managing asthma and engaging in 
crucial tasks for their age. Their descriptions pointed to the additional stressors and conflicts 
such efforts place on them and how this may contribute to anxiety symptomatology.  
To be more specific, in keeping with their developmental stage (Shaffer & Kipp, 2014), 
respondents made reference to their endeavour to form friendships and belong in a peer group 




being hindered by asthma symptoms and how this affected not only their feelings, but also 
how they worried their future might be.    
 “It’s like kind of like tough because... with my asthma I’m always in the house... 
and that is shortening my time with my friends... I think to myself “Oh no, if this 
keeps up I’m going to end up like, all my pals are going to end up thinking, 
they’ll just not have nothing to do with me and that. And I’m going to have to sit 
about in the house myself, always taking my inhaler and that” (Richard)  
  
In this context, others highlighted concerns regarding how this endeavour to negotiate their 
place in their peer group, whilst having asthma, influenced how they viewed themselves as 
“different” or “odd”, and as such affected another major adolescent task, the development of 
identity. 
“You couldn’t join in with stuff they [friends] were doing. You felt the odd one 
out” (Chris) 
 
Six participants presented a continuous identity negotiation between feeling strong versus 
vulnerable. One participant talked about viewing asthma as a drawback, keeping him from 
leading a normal life, but later reports investing all his efforts in maintaining his identity as a 
strong person, as an achiever, despite asthma.  
 
“It [asthma] is a drawback. I struggle and, well I used to. I’m slowly getting 
better but... if it becomes dormant in the future, obviously that’s good and I can 
really start to lead more of a normal unhindered life” (Lucas) 
 
“I just work through it because I can always reason with myself and say, “Oh 
yeah I was beaten because I’ve got asthma,” but in the end I don’t want people to 
say that. I want to be able to say, “Well I won them, sort of won against them, 
even though I’ve got asthma” (Lucas) 
 
Others also reflected on the impact of asthma on their identity and how this could drive their 
efforts, but could also place increased pressure on themselves to achieve despite their medical 
condition, potentially impacting on their anxiety.  
 




“The way I view myself, I feel like I can’t do as much as a normal person could 
because I’ve got limitations.  It [asthma] holds me back” (Simon) 
 
“Whereas asthma, for me, it can pull you back but I’m not going to stop. Because 
just say I’m in a game, then if I get really out of breath I’ll stop, take an inhaler, 
but then usually people will go sit out. I won’t. I’ll just take my inhaler, stop for 
maybe a minute or two and then go again. It doesn’t stop me” (Liz) 
 
 
The young people in this sample also expressed concerns about asthma affecting their efforts 
in achieving age-appropriate autonomy. Six young people provided descriptions of 
experiencing a conflict between their need to maintain increased closeness and support from 
significant others to manage their condition, whilst wanting to feel more independent. A 
sense of frustration emerged in many of the participants, as they discussed efforts to manage 
such conflicts.  
“I’d always be with someone... I don’t know it’s just in case anything happens... 
It’s not that nice because if I go out it then feels as if I’m following my, them 
[parents] around the shops, I don’t like the fact that I go out and can’t do stuff 
myself”(Chris) 
 
Some participants’ descriptions also depicted how significant others also had concerns about 
encouraging them in such developmental tasks, possibly maintaining anxiety-maintaining 
patterns of seeking safety and reassurance in others.  
“My teacher always says to me, Take it easy just in case. Keep your inhaler with 
you” (Clare) 
 
“Mum’s very over-protective and now if I have a cold or a snuffle she’ll quite 
often say to me, I don’t want you to go to school cause your asthma could flare 
up”(Lucas) 
 
3.1.2. Asthma as a barrier to valued, potentially coping, activities  
Related to the aforementioned subtheme, but potentially relevant to wider age groups, all 
participants invariably referred to perceiving asthma as a barrier to activities which were 
valued to them. Respondents described asthma to place barriers in their efforts to remain 




engaged in meaningful activities.  
 
“Well obviously if it’s bad then I can’t go to school and I can’t do like sport and 
everything. And it’s quite, yeah, quite annoying not being able to kind of, yeah, 
breathe properly” (John) 
 
“when it was particularly bad..., it affected my entire life basically; my 
education; my fitness; everything... School life became, was awful, because I 
was off every second week and I had really bad attendance; and I struggled 
through primary school because obviously it affected my education and I had to 
catch up a lot” (Lucas) 
 
 
Such valued activities, from spending time with friends, to education and fitness, may in 
some respects be crucial in participants’ efforts to cope with anxiety. Asthma may, thus, be 
perceived as a barrier to using such coping strategies. 
“Like doing sports just takes me to another place really. It just takes me away 
from everything... before I had asthma... I used to be really sporty. I still love 
sports and my asthma pulls me back... and my friends might not invite me out to 
play or something like that because I have asthma” (Liz) 
 
“I can’t concentrate and I’m too busy thinking about my asthma and school and 
worrying. It all just brings more.... my friends... like, sometimes I won’t speak to 
them for days because I’ll be kept in or things like that” (Jennifer) 
 
3.1.3. Asthma triggers worries and anxiety-provoking thinking patterns 
All participants readily discussed this relationship outlining how asthma symptoms may 
directly trigger worries and anxiety-provoking thinking patterns, indicating its role in 
maintaining anxiety.   
Some participants described asthma as an additional stressor in their lives, triggering worries 
or comprising another matter to worry about, rather than possibly causing their anxiety.  
“Everyone else worries about something else, I worry about asthma” (Simon) 
 
“I just don’t really want to have it [asthma] anymore, because it’s like [sighs] 
something else to worry about” (Ben) 





Anxiety-provoking thinking regarding asthma symptoms was also evident in respondents’ 
descriptions, with catastrophising during an episode being the most prominent.  
“I’d probably get worried that... if I was on a bed and they would like put on the 
masks on me, in case I was going to actually die” (Ben) 
 
“It does...panic me, Oh, god, there’s something really wrong with me” (Clare) 
 
“I just get really confused and worried and panicky. What do I do? What’s going to 
happen? Am I going to be OK?... Is it going to get worse in the future? Is it going 
to get worse now?” (Liz) 
 
 
Five participants perceived anxiety about asthma to be moderated by illness severity and how 
well-controlled the medical condition was thought to be.  
 
 “I think if I have quite bad asthma then, yeah, I might start worrying about what’s 
going to happen... but it’s not unless it’s really serious” (John) 
 
“if it’s bad, like over a period of time, I will be worrying “why is this and what’s 
gonna happen”... like will I have an asthma attack and have to go to hospital” 
(Amy) 
Participants not only noted worrying about the progress of asthma and the impact it may have 
on their bodies and future, but also referred to worrying about its impact on significant others. 
“I feel a bit bad because I don’t want my parents to worry about it more than 
necessary” (John) 
 
“I’m putting like pressure on other people who have to look after for me. I don’t 
like it very much” (Richard) 
 
3.1.4. Strategies to manage asthma over-generalise to managing anxiety, producing safety 
behaviours that maintain anxiety 
Respondents promptly pointed to a wide variety of coping strategies to manage asthma, 
including sitting down, focusing on their breathing, having their medication available, 




keeping helpful others close, being vigilant of potential asthma triggers and avoiding them. 
With years of experience of living with asthma, such strategies were readily described by all 
participants and appeared engrained in their ‘coping toolkit’. Nine of the respondents made 
reference to using such strategies in managing anxiety too, which may then represent safety 
behaviours that would be expected to be counterproductive, potentially perpetuating their 
worrying.  
For example, vigilance about potential asthma triggers is promoted in self-management 
programmes (Lehrer et al., 2002), but amongst participants in this sample, it appears to 
reinforce a constant state of alert. Thinking processes, such as hypervigilance and a positive 
attitude towards worrying (e.g., it helps me cope/prevent disasters) became apparent in 
respondent reports and may be expected to contribute to anxiety, in line with generalised 
anxiety models (Wells & King, 2006; Dugas & Robichaud, 2007) 
“I always have to worry, do I have my inhaler on me? Can I do that? If I have 
an asthma attack, will I be fine?  Yeah, I just have to think of all the things that 
might happen and then almost prepare for them” (Simon) 
 
“I need to be a lot more careful than obviously other people would have to be...  
I suppose, because I am worrying about it [asthma], it is making me, like, more 
aware of what is actually happening, so I am trying to prevent it even more, I am 
not that relaxed about it” (Amy) 
 
Other participants also described asthma coping strategies that could evolve to be unhelpful 
when used in the context of anxiety. Crucial examples referred to medication, lying or sitting 
down and being close to helpful others. Such strategies are important for asthma, but may 
generalise to invariably seeking safety in them to feel reassured and calm amongst 
respondents in this sample.  
“I make sure I’ve got, like, spare inhalers in case I lose one and I bring three or 
something in case… I get almost worried that I will use it and then I will run out 
of inhalers and then I will get, I will need an inhaler and then that will just be 




me worrying about having an asthma attack... I then worry about not having my 
inhaler and then it just gets worse from thereon” (Simon) 
 
“That’s why I start getting scared for that... it’s usually when your people aren’t 
here. Because if something happens to me I can just rely on them to help me... I 
feel like I’ve got no gas mask, not having my mum and dad with me” (Richard) 
 
“I get headaches when I’m nervous...mostly in school...I would take 
paracetamol and then just like cope until I go home... then I just go to bed and 
lie down” (Amy) 
 
3.2. The influence of anxiety   
Eight participants endeavoured to also consider this comorbidity from an opposite 
perspective pointing to how anxiety may influence asthma symptoms. They referred to how 
they perceive their anxiety-related behaviours and symptoms directly triggering asthma 
symptoms and indirectly affecting appropriate asthma care and treatment adherence.  
3.2.1. Physical symptoms of anxiety and anxiety-related behaviours trigger asthma  
Six respondents described anxiety-related symptoms triggering asthma symptoms. 
Participants focused on hyperventilation in the context of anxiety impacting on their airway 
and chest functioning.  
 
“you start breathing a bit faster and I think that’s, it’s not really the fright it’s 
more the sudden faster breathing that kind of brings on the asthma" (John) 
 
“the anxiety would mean my breathing would increase which then made me feel 
horrible in my chest.  It would then start the asthma” (Chris) 
 
Respondents also considered situations where anxiety-related behaviours brought on asthma 
symptoms.  
 “Like, sometimes I do find it quite hard to breathe if I start worrying about 
something, then I find it hard to catch my breath and I start crying and feeling 
really shaky. If I ... I run away and obviously running impacts it” (Clare) 
 




“Sometimes if I start crying and stuff it’ll affect my asthma because when I cry I 
can’t breathe” (Jennifer) 
 
3.2.2. Anxiety inhibits good asthma care and medication adherence 
Respondents made reference to experiences where anxiety may secondarily contribute to 
asthma complications though preventing appropriate use of inhalers. Participants frequently 
responded to anxiety-related symptoms with asthma medication, resulting in potentially 
overusing their reliever inhalers and making themselves vulnerable to side effects (NICE, 
2008; Newhouse et al., 1996; Taylor et al., 1996). 
“Then things like exams would make me nervous the same way, lightheaded and 
sick almost, but I could feel my breathing start to go...and I’d just panic. My 
deep breaths and take my inhaler, just control it and stay calm” (Chris) 
 
“In primary school, if we had to do something worrying... I would usually get 
quite chesty... And kind of finding it harder to breathe, so I took my inhaler and 
it was better” (Craig) 
 
In addition, during asthma episodes participants acknowledged that worrying about how their 
medical condition may evolve prevented appropriate problem-solving and, thus, asthma care.  
“Because I always think of the worst. I can’t make something good with my 
asthma because I’m too busy worrying” (Jennifer) 
 
“When I have an asthma attack... then I will get really worried and I’ll get quite 
 panicky and I won’t just sit down and take a deep breath, I’ll be like, “What do I 
do, what do I do?”... The times in the past that I’ve had an asthma attack or my 
asthma’s been really bad, I hadn’t taken my inhaler properly because I’d been 
that worried. I get confused, that kind of feeling” (Liz) 
 
Within this context, one participant also shed light on how anxiety regarding social situations 
may also affect medication adherence.  
“It is more if I have to take my inhaler in front of people; I don’t like doing that, 
cause they might think I’m on drugs or something” (Craig) 
 




3.3. The interaction between asthma and anxiety 
The last super-ordinate theme refers to six participants’ attempts to approach this comorbidity 
in non-linear terms of one leading to the other, but describing experiences of asthma and 
anxiety in patterns of interaction and acknowledging a more complex interplay between the 
two conditions. 
3.3.1. Asthma and anxiety interact forming a positive feedback loop  
Five participants provided descriptions of asthma and anxiety symptoms in a self-
perpetuating feedback cycle, which may maintain this comorbidity. Participants provided 
examples where they experienced difficulties in identifying stages within this cycle where 
they could intervene and prevent it from escalating.  
“If I feel out of breath, I might start to worry that I’m going to have an asthma 
attack, start breathing heavier and then that invokes my asthma more... but 
because I’m worrying about having an asthma attack while I’m a wee bit bad on 
asthma, then all of a sudden that might just trigger it and then I could actually 
have an asthma attack...then it will be that circle again and then I’ll get worried 
and then it will get worse, worrying that I’m making it worse by worrying and 
then I just can’t get out of it until it ends basically” (Simon) 
 
“my worrying is like it’s trying to help my asthma beat me, beat like [sighs] beat 
me! It’s like they’ll help, try help each other like to beat me” (Richard) 
 
One participant explains that the trigger for this vicious interactive cycle may equally be 
asthma or anxiety symptoms.  
“If I ever had an asthma attack it would make me nervous and anxious so and 
then I would get worked up and it would make the asthma worse.  Then because 
the asthma would get worse I would get more anxious, it would keep going and 
both would get worse, and worse, and worse until my asthma was really bad and 
we would have to phone an ambulance and go to hospital... If I was anxious I 
would start breathing quickly which would then make my asthma come on if I 
started to get tight in my chest, and then it would be the other way about so then 
my asthma would get worse because of the anxiety.  Again they would both get 
worse and worse because I was nervous” (Chris) 





Participants reported prioritising asthma management (i.e., medication/sitting down) when 
experiencing this interaction between asthma and anxiety, whilst acknowledging the 
importance of managing the panic symptoms, by seeking re-assurance from helpful others, 
using distraction, or trying to balance worrying thoughts.   
 “I just focus on the fact that, right, I’ll deal with that asthma and then I’ll think 
about other stuff later because, at the moment, the asthma is my number one 
priority, to make sure I get better” (Simon)  
 
“I have to try and keep things together so I will be able to breathe. I just try and 
think of the positive side of it and then I just try and take my inhaler more or 
take more of my medicine, whatever. I just have to calm myself down and try and 
do something else and watch TV to try and take it off my mind” (Jennifer)  
 
“Well, my inhalers obviously help me but my mum will be there for me if I want 
to talk about it” (Liz) 
 
Salbutamol use, however, is associated with common adverse effects, such as palpitations, 
anxiety and hyperventilation (NICE, 2008), all of which could further feed in to the vicious 
interactive cycle, making it almost impossible for young people to ‘escape’. 
3.3.2. Confusion between symptoms of asthma and symptoms of anxiety 
Four participants made reference to situations where the distinction between the physical 
symptoms of anxiety and the asthma symptoms became less definite, aggravating decision-
making regarding the appropriate reaction.  
“I was, like, right, I need to take my inhaler. I don’t have it, and then I started 
really worrying and then that caused me to actually have an asthma attack... 
That probably… if I realised I don’t have asthma, I just sit down and make sure I 
breathe slower, then I would’ve been fine” (Simon) 
 
“I was sitting there. I think I was worrying, but then... I can just remember 
worrying and then taking my inhaler. So... I don’t know if that was one of the 
two” (Liz) 
 




This theme is related to previous themes discussing inappropriate medication use in the 
context of anxiety symptoms. Participants in this sample may be particularly vulnerable, as 
managing asthma in situations where both symptoms co-occur appeared to be a priority for 
them; such priority is of course in keeping with asthma self-management guidance suggesting 
early intervention before symptoms deteriorate (Lehrer et al., 2002). However, the decision 
regarding the suitability, or not, of medication use in such ambiguous situations may not be 
as straightforward, especially in the context of reported experiences of physical symptoms of 
anxiety triggering actual airway obstruction symptoms.   
4. Discussion 
The current study offers an insight into the mechanisms linking asthma and anxiety as 
experienced by young people (11-15 years) living with symptoms of both conditions. 
Analysis endeavoured to consider factors that may maintain this relationship, approaching it 
both in linear terms, describing participants’ experiences of one condition influencing the 
other, and as an interaction examining more complex ways in which this comorbidity may 
affect participants’ lives. The study provides rich qualitative data to support previous findings 
in this field regarding the manifold links between the factors in question (DePeuter et al., 
2008; Feldman et al., 2009; 2005; Lehrer, 1998; McGrady et al., 2010; Meuret & Ritz, 2010), 
whilst adding novel conceptions about the patterns that may maintain this comorbidity. It 
further provides good evidence regarding the increased awareness young people have about 
experiences that may perpetuate the comorbidity, indicating that such hypotheses can be 
tested directly by children and adolescents rather than by proxy through professionals and 
parents. However, participants appeared less able to recognise such experiences as 
maintaining mechanisms and consider strategies to prevent them. The present research 
suggests that this could be the specific focus of psychological treatment protocols tailored to 




manage this comorbidity. 
The first theme focused on the unilateral impact of asthma-related factors on anxiety 
symptoms. The findings confirmed that perceiving asthma as a barrier to meaningful and 
potentially anxiety-relieving, coping activities may play a crucial role amongst young people 
with asthma and anxiety, which is consistent with previous research indicating that viewing 
asthma as significantly affecting one’s life and limiting activities mediated the asthma and 
anxiety comorbidity amongst adolescents (McCauley, Katon, Russo, Richardson, & Lozano, 
2007; McGrady et al., 2010). The current study further suggests that asthma may be 
perceived as threatening not only to valued activities, but also to major developmental tasks 
for young people, placing additional stressors and conflicts on them, thus contributing to 
anxiety symptomatology. Respondents described continuous efforts to minimise or negotiate 
asthma’s impact on developmental tasks, such as achieving age-appropriate autonomy, 
forming friendships, maintaining a sense of belonging and establishing an identity (Shaffer & 
Kipp, 2014). Such developmental conflicts, thoughts and perceptions regarding the impact of 
asthma may need to be defused or modified in a tailored psychological treatment in order to 
promote long-term improvements.  
Within this super-ordinate theme, the present research confirms previous evidence 
highlighting the impact of catastrophic thinking regarding asthma symptoms, both in general 
and during an episode, on maintaining anxiety amongst individuals with asthma and anxiety 
(DePeuter et al., 2008). Contrary to quantitative research outcomes suggesting that the 
association between asthma and anxiety is independent of objective pulmonary function 
(Feldman et al., 2009; Rietvield et al., 2005), almost half of the respondents in this sample 
perceived illness severity as moderating the relationship between asthma symptoms and 
catastrophic thinking. Besides catastrophic thinking, this study further identified additional 




unhelpful and anxiety-maintaining thinking and behaviour patterns. Effective asthma self-
care strategies, reinforced over years of living with the condition (i.e., sitting down, focusing 
on respiratory function, having medication available and using them early when identifying 
symptoms, keeping helpful others close, being vigilant about potential asthma triggers and 
avoiding them), may over-generalise to being used for managing anxiety too, which would be 
expected to be counterproductive, potentially perpetuating worrying. Indeed, cognitive 
processes such as hypervigilance and holding positive beliefs about worrying (e.g., it helps 
me cope/prevent disasters, like exposure to asthma triggers) have been identified as 
maintaining factors in well-evidenced generalised anxiety models (Wells & King, 2006; 
Dugas & Robichaud, 2007) and may maintain anxiety in this context too. In addition, coping 
behaviours, such as medication or seeking re-assurance from significant others are likely to 
be effective with asthma symptoms, but when used with ambiguous or anxiety symptoms, 
they may prevent individuals from habituating to anxiety, experiencing that nothing 
catastrophic happens, and developing more suitable strategies (Clark, 1986; Warwick & 
Salkovskis, 1990), thus gaining mastery in managing anxiety. The present findings shed light 
to potential systemic factors further reinforcing such safety-seeking strategies with highly 
protective responses from family and school. Further quantitative research is warranted to 
confirm such anxiety-maintaining patterns in the context of asthma with larger samples, but 
their modification would appear critical in ensuring long-term positive outcomes.   
The second super-ordinate theme was related to mechanisms explaining the reverse function 
of this comorbidity. Qualitative data in this study provide evidence to support original 
hypotheses within this field regarding the key role of breathing and physical symptoms of 
anxiety in exacerbating asthma symptoms (Carr, 1998). These are in keeping with outcomes 
linking hyperventilation with bronchoconstriction (Frieri, 2003; Meuret & Ritz, 2010), with 
participants in this study providing vivid examples of such processes. Such narratives 




potentially point to designing interventions that promote awareness of these processes, 
potentially enriched with relaxation or mindfulness-based interventions to target 
physiological symptoms of anxiety. 
In the third super-ordinate theme, respondents’ experiences appeared to be consistent with the 
concept of an unhelpful feedback loop between asthma and anxiety symptoms, where either 
of which may activate a cycle of one condition exacerbating the other in a continuous 
process. Amongst participants in this sample, preventing this loop before escalating appeared 
more difficult, but at the peak of this self-perpetuating cycle respondents described asthma 
management as becoming a priority. This of course is complicated by experiences of 
symptom confusion, compromised care strategies and anxiety-triggering medication side-
effects, as highlighted earlier in this study. 
To be more specific, in line with previous research pointing to the complications of the 
symptom overlap between the two conditions, primarily symptom confusion and 
subsequently inappropriate care (Lehrer, 1998; Schmaling & Bell, 1997), the current analysis 
also revealed difficulties in the distinction between the physical symptoms of anxiety and the 
asthma symptoms amongst respondents, aggravating decision-making regarding appropriate 
reaction. However, the decision regarding the suitability, or not, of medication use in such 
ambiguous situations may not be as straightforward, especially in the context of reported 
experiences of physical symptoms of anxiety triggering actual airway obstruction symptoms 
and asthma management guidance suggesting early intervention before symptoms deteriorate 
(Lehrer et al., 2002). In addition, the current study further adds to these findings, showing 
within the second master theme that worrying during an asthma episode may also prevent 
effective problem-solving and appropriate inhaler application, which may also account for 
medication overuse (Feldman et al., 2009; 2005). Such experiences may further explain 




outcomes of CBT trials resulting in a deterioration in physiological anxiety for children that 
also suffer from asthma (Papneja & Manassis, 2006). This indicates that potentially enriching 
standard anxiety treatments with techniques to train young people to differentiate between 
physiological states is likely to be crucial for this comorbidity. 
Finally, it may be worth pointing to the fact that the emergent subthemes were supported by 
at least one third of the respondents, indicating that the majority experience multiple 
connections between asthma and anxiety symptoms, which may further increase complexity 
and strengthen this comorbidity.  The cumulative impact of experiencing the symptoms of 
both conditions, and essentially the sequelae of a mental health and physical health 
comorbidity on respondents was evident throughout the analysis. This challenge has long 
been identified by researchers (Merikangas et al., 2007) and national policies (DoH, 2014; 
Scottish Government, 2012) and expedites the urgency of effectively treating such co-
morbidities. 
4.1. Implications for clinical practice, policy and future research  
The present research was designed to respond to a clinical need regarding tailoring 
psychological interventions for the comorbidity between asthma and anxiety, a process which 
requires an increased understanding of the subjective experiences of the clinically relevant 
population.  
Potential maintaining patterns discussed within this sample may be used as a guide to inform 
clinical assessments in paediatric psychology settings, working with respiratory patients. 
Findings may also be suitable to guide the development of a screening inventory to contribute 
to the initial assessment process. As items would directly emerge from the experiences of 
young people with similar difficulties, potentially using language from their extracts, this 
could raise its content and face validity. Such a measure may also assist in future studies that 




are clearly indicated in order to test the applicability of the proposed mechanisms with larger 
samples, using quantitative methodology.  
The proposed mechanisms lend themselves to a cognitive-behavioural approach and may be 
used to tailor psychological treatments for children and adolescents with asthma and anxiety. 
Analysis revealed explicit anxiety-maintaining thinking patterns relevant to this population, 
developmental conflicts, cognitive misinterpretations and counter-productive behaviours that 
can potentially be defused or modified utilising a specifically-designed CBT approach, 
informed by third wave CBT techniques. In relation to the third master theme, in particular, 
narratives point to difficulties in the differentiation between physiological states of asthma 
and anxiety and symptom confusion. Mindfulness-based interventions may prove valuable in 
allowing young people to identify and discriminate between elements of their experience, 
focusing less on reducing their symptoms directly and more on developing a non-judgemental 
and non-reactive awareness of these. Such an approach may potentially allow them to 
disengage from the unhelpful feedback loop of their symptom interaction and may also 
improve unnecessary medication use. Future research would be required to pilot such a 
treatment, potentially utilising multiple-baseline designs to evaluate its effectiveness across 
subjects; this would also correspond to national policies about prioritising the development of 
effective and suitable psychological treatments for individuals with mental health and 
physical health co-morbidities (DoH, 2014; Scottish Government, 2012).  
In addition, as young people with asthma and anxiety often do not meet the threshold for 
referral to mental health services -although they still have a clinically significant need- the 
results could assist in the development of tailored self-help material to raise awareness 
regarding potential counterproductive thinking or behaviour patterns relevant to this 
comorbidity and techniques to manage them more effectively. Self-help interventions would 




contribute to early intervention and health promotion targets in relevant national policies 
(Scottish Executive, 2005).    
Finally, consistent with studies highlighting that anxiety is highly under-detected amongst 
patients with asthma (Chen et al., 2006), despite its manifold impact on the management of 
the condition and on well-being, the results once again draw attention to the effect of anxiety 
on childhood asthma. Findings may inform respiratory assessments, by pointing to anxiety 
mechanisms potentially complicating asthma care, which may need further exploration and 
input to resolve. In light of further evidence from this study, it appears essential that asthma 
policies and clinical practice guidelines stress the importance of early identification of 
anxiety by key workers in respiratory care and recommend subsequent referral for 
psychological input, where appropriate. This could, in turn, reduce anxiety-related asthma 
complications, promote suitable use of medication and, thus, enhance long-term outcomes 
and improve young people’s quality of life. As noted previously, anxiety has also been linked 
with increased pressures on health care, i.e., longer hospitalisations and overtreatment 
medical responses (Fernandes et al., 2010), and it is therefore expected that empirically-based 
effective input from psychological services may benefit the health organisation long-term.  
4.2. Strengths and limitations 
The present research benefits from being the first to have explored the lived experience of the 
interaction between asthma and anxiety directly from the perspective of children and 
adolescents using qualitative methodology.  
Qualitative research evaluative criteria (Yardley, 2000; 2008) and IPA quality assessment 
recommendations (Smith, 2011) were followed to increase the credibility and rigour of the 
analysis. The recruitment method benefited from the use of a randomly selected and 
homogeneous clinically representative sample, from multiple sites; although generalisability 




is limited by the small number of participants and the lack of information regarding the 
characteristics of the high rate of the invited children and adolescents that chose not to 
respond (85.72%).  
Only one participant had asthma duration of two years or less, which may have limited the 
emergence of issues of adjustment to new diagnosis in relation to the comorbidity. Illness 
severity in the current sample was variable and measured only by self-report at the time of the 
interview. This responded to evidence showing illness severity not predicting anxiety 
amongst individuals with asthma (Feldman et al., 2009; Rietvield et al., 2005). On retrospect, 
however, it may have been useful to have accessed an objective measure of asthma severity.  
As with all qualitative studies, considerations arose in relation to the role of the researcher in 
the process and analysis, especially given the authors’ familiarity with this domain. This was 
managed by having expectations logged a priori to increase awareness of potential 
confirmatory bias, having a random selection of the interviews second-coded and seeking 
validation of the initial interpretation of the findings through important stakeholders and 
respondents. In IPA, researchers’ existing knowledge and prior experience is viewed as a 
strength within the double hermeneutic process of the later stages of the analysis (Smith et 
al., 2009). Furthermore, the availability and use of prompts during the semi-structured 
interviews, where appropriate (Appendix H), may also be viewed as increasing bias and 
leading responses. The provision of prompts was in line with IPA methodology (Smith et al., 
2009) and guidelines regarding qualitative interviewing with young people (Docherty & 
Sandelowski, 1999). Finally, limitations exist in relation to the lack of a comprehensive 
assessment of data saturation. However, the relatively homogeneous sample and focused 
research question, in addition to the prevalence of each subtheme in at least one third of the 
transcripts, may increase the consistency and credibility of the reported subthemes.   





This research contributes to existing knowledge regarding young people’s experience of 
living with asthma and anxiety and adds novel conceptions regarding the mechanisms that 
may maintain this comorbidity via a more in depth analysis. Findings were summarised in 
three major themes: i) the influence of asthma by inhibiting valued coping activities or 
developmental tasks, triggering catastrophic thinking and leading to an over-generalisation of 
asthma coping strategies to managing anxiety; ii) the influence of anxiety via affecting 
appropriate use of medication and triggering hyperventilation-induced asthma exacerbations; 
and iii) the interaction between asthma and anxiety by forming an unhelpful positive 
feedback loop and triggering symptom confusion. This report outlines how findings could 
inform clinical practice guidelines, guide assessments, contribute to the development of a 
conceptual model and in the adaptation of psychological interventions.  
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III. EXTENDED METHODOLOGY CHAPTER 
This chapter expands on aspects of the methodology of the empirical study not outlined in the 
main journal article. 
1. Additional ethics considerations  
Approvals were sought and obtained by the West of Scotland Research Ethics Service and the 
local Boards’ Research and Development (R&D) offices (Appendix C). 
1.1. Protecting confidentiality 
Steps were undertaken to safeguard confidentiality and anonymity. All questionnaires and 
contact information forms returned at the initial screening stage were stored in a lockable 
cabinet within secure NHS premises and were only accessible by the main author and the 
clinical supervisor. Digital recordings of the interviews were safely stored on an NHS 
network drive and were only accessible to the main author and clinical supervisor. Consent to 
retain anonymised data at the University of Edinburgh for research governance purposes and 
for use in future research was explicitly obtained. Each participant taking part in the 
interview was assigned a pseudonym and all data (questionnaires and transcripts) were 
labelled using this pseudonym and were cleared of any identifiable information. This was 
monitored by the main author's clinical supervisor.  
1.2. Obtaining informed consent/assent  
The information sheets inviting families to participate contained comprehensive information 
regarding all stages and aspects of the research project (Appendix D), including consent or 
assent to take part, ability to withdraw at any time without this affecting their treatment, and 
actions taken to protect confidentiality, safeguard participants and manage potential distress. 




Explicit explanations were provided regarding the use of direct but anonymised quotes from 
the interviews in the presentation of the research outcomes. The information sheets were 
adapted to be understandable and engaging, excluding jargon and technical terms. In line 
with current practice, two information forms were available for young people, one with even 
more simplified language for participants below the age of 12.  
Implicit consent to take part in the initial screening stage of the study was assumed by 
returning their contact details and the screening questionnaires. Families were invited to 
contact the main researcher for additional information and were provided with an opportunity 
to clarify aspects of the study during the telephone conversation to arrange the interview 
appointment for the main stage of the study.  
Guidance from the Scottish Children's Research Network (ScotCRN, 2012) was followed 
regarding obtaining written consent. It is suggested that all children below the age of 16 are 
considered competent to provide informed consent for a study should they be facilitated to do 
so appropriately (ScotCRN, 2012). Consequently, during the initial part of the interview the 
main author discussed the purpose and stages of the study in accessible language and 
encouraged families to ask questions to help clarify potential misunderstandings. 
Subsequently, written consent was sought by all participants above the age of 12 years and 
written assent was obtained by all parents/guardians who accompanied participants. In 
keeping with guidance from local R&D departments, written assent was sought from young 
people below the age of 12 with parents/guardians providing written consent (Appendix E). 
Competency to provide informed consent was assessed by the main author during the initial 
part of the meeting. This assessment was in line with evaluations of competency to consent to 
treatment, which the main author has undertaken routinely in clinical practice. In consultation 
with the researcher’s clinical supervisor, this included an evaluation of participants’ 




understanding of the nature of the project and ability to describe the stages it involved, 
possible implications, awareness of the right to withdraw at any time, and how their data 
could be used.  
1.3. Safeguarding participants  
Participants’ GPs were notified by a letter regarding their participation (Appendix F). All 
parents or guardians of potential participants who scored above the recommended threshold 
on the anxiety questionnaire were sent a standard letter to advise them of this and to 
encourage them to explore it further with their GP. This letter also provided website links 
with age-appropriate self-help material (Appendix G). 
Talking about a chronic medical condition and anxiety can potentially be difficult. In an 
attempt to ensure that the main author approached these issues sensitively and appropriately, 
the interview schedule was piloted with three adults with childhood onset asthma and their 
feedback was used to improve the style and manner of the interviewer. One pilot interview 
was also reviewed by the main author’s clinical supervisor to facilitate this process. 
Prior to the start of the interview all participants were informed that should issues arise, 
including risk disclosures, permission would be sought to contact their GP and additional 
psychological support by the aligned child and adolescent mental health services could also 
be offered. A plan was in place to discuss risk management with the main author’s clinical 
supervisor, to agree the appropriate action in line with relevant NHS regulations. Although 
the interviews were not expected to cause distress, the main researcher monitored 
participants' affect throughout to ensure that immediate support would be offered if 
necessary. Regular academic and clinical supervision was utilised for any unforeseen issues. 
Families were provided with key contact information if they became concerned about any 
aspect of the study.  




1.4. Issues related to the researcher  
The interviews were all conducted in clinical settings, although participants were invited to 
select a venue that would make young people feel calm and relaxed, which could be outside 
NHS premises, e.g., family home. To manage associated risks, the main author would follow 
the local NHS lone working policy. 
1.5. Ethics of interpretation  
Another consideration referred to the debate regarding the ethics of interpretation in 
qualitative research, which highlights that such processes can potentially be distressing or 
harmful for participants when overanalysing or misreading their narratives (Willig, 2012). 
Methods adopted in the present study in order to preserve the idiographic aspect of IPA and 
to ensure quality in the analysis, also allowed to manage such considerations, i.e., respondent 
validation, second-rating of transcripts, actively looking for alternative interpretations, 
remaining close to respondents’ “voice” and focused on the research aims (Willig, 2012).   
2. Procedure 
2.1. Recruitment 
In qualitative research the number of participants required depends on the breadth of the 
questions, the homogeneity of the sample and the richness of the data (Smith & Eatough, 
2007). A sample size of six to ten interviews was considered viable for this study, given the 
time constraints of a project undertaken for a clinical doctorate course (Smith et al., 2009). A 
sample size of this level was also considered suitable given the focused research question in 
one targeted aspect of participants’ lived experience and the implementation of eligibility 
criteria that allowed the recruitment of a closely specified homogeneous group. However, 
given that young people participated, whose verbal skills were likely not to be fully 




developed, more respondents were aimed to ensure adequate richness in the findings. The 
sampling procedure took place between April and October 2014. Within this time frame, 
eleven participants were recruited. 
The local respiratory teams initiated the approach of potential participants registered in their 
clinics by post. At this stage the research team was not involved and as such the local 
Caldicott Guardian advised that specific approval was not necessary. NHS Lanarkshire, NHS 
Lothian and NHS Greater Glasgow and Clyde tertiary paediatric asthma services agreed to 
participate, with only the former two eventually disseminating the research invitation letters.  
In order to ensure that no more families would be contacted than necessary, a random 
selection of 187 young people (using a randomised sequence generated by random.org) from 
the Lanarkshire and Lothian tertiary asthma registers were initially sent the information packs 
and screening questionnaires. As previous studies suggested that postal recruitment typically 
results in 20-25% return rate, it was expected that approximately 40-45 questionnaires would 
initially be returned. Out of those potential participants, based on published prevalence rates 
(Vila et al., 2000), it was expected that 1/3 would report increased anxiety symptomatology, 
resulting in approximately 14 children. These would be screened to evaluate if they meet the 
rest of the eligibility criteria and would subsequently be invited to the interviews. In practice, 
as at this stage only nine young people were recruited, a random selection of a further 44 
information packs were sent, resulting in a total of eleven participants meeting eligibility 
criteria and attending the interviews. 
2.2. Eligibility criteria 
Inclusion criteria 
 Young people aged 11-16 years to ensure that participants had sufficiently developed 




verbal skills to articulate their views and experiences.  
 Young people with a diagnosis of asthma in accordance with the British Thoracic 
Society/Scottish Intercollegiate Guidelines Network (2008). As research suggested 
illness severity is independent of the association between asthma and anxiety (Rietvield 
et al., 2005), the level of asthma impairment was not set as an inclusion factor.   
 Young people whose total score on the SCARED anxiety screening questionnaire was 
equal to or above the cut-off score of 22 (Desousa et al., 2013). 
Exclusion criteria 
 Young people with a recent diagnosis of childhood asthma were excluded. Recent 
diagnosis is commonly associated with increased parental and child anxiety as part of 
the adjustment process to the condition and its challenges (Gupta et al., 2001). 
Although the length of the period needed to adjust to a chronic condition may vary 
dependent on a range of factors (Christie & Khatun, 2012), a minimum of six months 
since diagnosis was considered adequate in consultation with the paediatric psychology 
and the respiratory team.  
 Young people with other physical health conditions, not related to asthma. Other atopic 
conditions (e.g., allergies or eczema) were not excluded as these are highly co-morbid 
with asthma (Rees et al., 2006) and affect a large percentage of the asthma population.  
 Young people with severe mental health difficulties (e.g., psychosis), pervasive 
developmental disorders or learning disability that would affect their ability to 
communicate their views and capacity to provide informed consent.  
 Non-English speakers. The interviews required sufficient verbal fluency. In addition, 




the anxiety questionnaire was standardised in the English language and its translation 
could compromise consistency and the validity of using the suggested cut-off score.    
3. Data collection   
3.1. Developing the interview guide 
An interview schedule was developed to ensure the process focused on the research aims. In 
line with guidance in IPA, this schedule was used in a semi-structured, non-prescriptive and 
non-rigid manner (Smith et al., 2009). It was developed in consultation between the research 
team and designed following the principles published by Smith and Eatough (2007), i.e., 
initial questions were open and reflective to allow participants to express their own 
perceptions and experiences, with probes available to ensure that the interview covers all 
areas relevant to the research objectives. Although particular consideration was paid to 
ensuring that the questions were not leading, specific prompts about areas to consider were 
thought necessary for young people in this study. This was in keeping with methodological 
considerations about interviewing children and adolescents, and managing developmental 
limitations in recalling or verbalising (Docherty & Sandelowski, 1999). Although, 
researchers previously queried the validity or efficiency of qualitative interviews with 
younger people, sufficient evidence currently exist that qualitative methods with children and 
adolescents can be extremely informative, allowing us to step outside the boundaries of our 
adult perspectives, and may be less directive than using inventories or scales that inevitably 
cue responses (Eiser & Morse, 2001; Mishna et al., 2004). 
In line with the objectives of the study, the interview schedule aimed to examine all aspects 
of the experience of living with asthma and anxiety, including cognitions, personal 
attributions, emotions, physiological reactions and coping behaviours or management 
strategies. The guide was piloted with three adult volunteers with childhood onset asthma. 




Their comments were used to amend the wording and approaching of questions, with 
feedback elicited by employing cognitive interviewing techniques at the end of the pilot 
interviews (Haeger et al., 2012). In particular, the retrospective verbal probing techniques 
included comprehension probes (“what does this term mean to you?”), paraphrasing probes 
(“how else would you express this question?”) and general or recalling probes (“what was 
difficult in answering this question?”, “what did you recall to respond to this question?”) 
(Willis, 1999). The pilot interviews were audio-recorded and the final interview was 
reviewed by the clinical supervisor in order to revise the schedule and refine the main 
researcher’s interview style and technique. 
4. Analysis 
4.1. The underpinnings of IPA 
IPA is informed by three philosophical strands, namely phenomenology, hermeneutics and 
idiography (Smith et al., 2009). It is phenomenological as it is concerned with how 
individuals perceive their world and reflect on their lived experience (Smith & Osborn, 
2003). It involves a ‘double hermeneutic’ approach, referring to the individuals’ attempt to 
make sense of their experience and the researcher’s effort to make sense of the individuals’ 
accounts (Smith et al., 2009). As the researcher’s approach is filtered by their own 
perceptions, experiences and pre-existing beliefs, it guides the researcher to engage in the 
analysis adopting an open, reflexive position (Starks & Trinidad, 2007). IPA also adopts an 
idiographic approach in that the inquiry is not focused on the population level, but it 
examines the individual’s particular accounts of their experience and efforts for meaning 
making as they cope with aspects of their lives (Starks & Trinidad, 2007).   
 




4.2. Choosing a qualitative research method 
IPA is the approach of choice in qualitative healthcare research (Reid et al., 2005) and is 
therefore extensively tested for its ability to contribute to this field. To date it has had a 
substantial impact in deriving patients’ experiences of conditions or treatments in a number 
of areas, including genetics (Michie et al., 2003), cancer (Jarrett et al, 1999) and pain 
(Osborn & Smith, 1998), leading to improvements and developments in the provision of care 
and treatment, which was consistent with the aims of this project. IPA is also extremely 
detailed as a framework and, thus, sufficiently accessible for a novice researcher. In addition, 
it is compatible with current psychological models, such as CBT, as it takes a theoretical 
stance of assuming a connection between participants’ talks, thoughts and affect (Smith & 
Eatough, 2007). IPA also places increased emphasis on the researcher’s subjective stance and 
predispositions. Although a reflexive approach to pre-existing assumptions and knowledge is 
inherent in most qualitative methods, including IPA, such preconceptions and understandings 
are also integrated in the analytic process of IPA; they are acknowledged and become 
transparent in the interpretations within the double hermeneutic approach (Smith et al., 
2009), which resonated better with the main researcher. The principles of IPA were, 
therefore, considered to fit appropriately with the aims of the study. Alternative established 
methodologies were also examined, namely discourse analysis and grounded theory. While 
these approaches have some commonalities and could have differentially informed the 
research question, when all factors were weighed, IPA was selected for the present study.  
To be more specific, discourse analysis is concerned with how the individuals use language 
to construct identities or realities and accomplish activities (Starks & Trinidad, 2007). 
Although some consideration of the impact of discourses on self was important in the 
analysis, overall this method’s aims and theoretical framework were felt to be less relevant to 




the study aims. It was therefore deemed that the impact of language alone was less efficient 
in describing participants’ realities and experiences in this context and in facilitating the 
study objectives.  
Grounded theory, on the other hand, is concerned with developing a theory to explain social 
processes and the method is designed to allow concepts to become evident from the data 
(Starks & Trinidad, 2007). This focus extended beyond the aims of this study, which was 
seeking to understand a phenomenon by exploring an aspect of participants’ individual 
experience. Less emphasis is placed in grounded theory on the analysts’ predispositions and 
subjective stance, and Glasser (1998) discourages early reading in the topic to ensure an open 
position. In the present project, this would have been challenging given the lead author’s 
prior clinical experience. The limited resources and time of the researcher would also 
potentially challenge the ability to achieve a sufficient number of participants for theoretical 
saturation, which is pertinent in grounded theory and this was also accounted for in the 
decision-making regarding the most appropriate method. 
4.3. Transcription 
In line with Yardley’s (2000) recommendations to improve commitment and rigour in the 
analysis, the transcription was undertaken by the main researcher. As IPA focuses more on 
interpreting the content of the respondent’s narrative, rather than on a detailed linguistic 
analysis, utterances, pauses or laughter were recorded, but without extensive details and exact 
lengths, in keeping with this method’s suggestions (Smith et al., 2009). In addition, guidance 
was also followed in relation to initiating transcription after all interviews were completed 
(Smith & Eatough, 2007). This was to ensure that the main author remains true to the 
method’s idiographic focus and does not impose informal interpretations emerging at 
transcription stage with respect to the manner the final interviews were conducted.  




4.4. Respondent and stakeholder validation 
Participants and their parents, as important stakeholders, were invited to feedback on the 
initial interpretation of the findings either through telephone contact or written response 
(Appendix I). Six of the eleven participants contributed to this stage of the study, all by 
phone. 
Overall, young people reported that the themes largely provided a good representation of 
their perceptions and attributions regarding their experience of the interplay between asthma 
and anxiety. In order to ensure that they were provided enough space to express their personal 
and potentially alternative views, young people were purposefully asked questions such as: 
“are these in any way different to your experience of living with asthma?”, “have I covered 
all the areas that were important to you?”, “was there another way of viewing the results?”, 
“was there any theme that surprised you, or was unexpected, or you felt was less relevant to 
you?”. Such questions prompted young people to discuss aspects of the master themes that 
were less representative of how they would describe or interpret their experiences.  
The themes that young people reported to be relevant to them were in agreement to the 
themes attributed to them in the initial analysis (see Appendix J for details). This 
demonstrated rigour in the findings and increased the credibility and trustworthiness of the 
interpretation. Three participants reported identification with more subthemes than initially 
revealed in their individual transcripts and provided examples of such experiences. 
Consequently, their original transcripts were revisited to check if they contain evidence of 
these additional themes; if not, then these additional subthemes would not be attributed to 
them. In any case, such reports increased confidence that the identified themes covered a 
wide range of experiences of living with asthma and anxiety. Similarly, one participant 
reported that the third theme was not relevant to them, despite this theme having been 




identified in their interview. Their transcript was revisited with the supervisor and it was 
agreed that the relevant quotes clearly described the relevent subtheme and that this may be 
an issue of limited awareness.  
The same process was followed with parents, who were asked similar questions. Parents also 
identified more subthemes to be relevant to their experience of bringing up a child with 
asthma, than initially revealed within their children’s transcripts, which further increased 
confidence in the credibility of the findings. They reflected on how complex this comorbidity 
appeared to be and provided examples how the initial themes informed the way they 
interpreted some of the behaviours they had previously observed at home. Interestingly, two 
were able to progress this interpretation further by starting to consider strengths and 
protective factors in their children and it was agreed that the interview was not sufficiently 
geared towards exploring what protects young people from further deteriorations in their 
asthma or anxiety.  
Finally, the specialist nurses involved in the recruitment process were invited to review the 
initial results of the analysis and assist in the final interpretation. They added to the 
interpretation by encouraging the lead author to consider the side effects of reliever 
medication, including palpitation, anxiety and tremor, which were subsequently incorporated 
as factors within the second and third super-ordinate themes. They further indicated that it 
was unexpected to see the impact asthma has on young people’s lives and how this influences 
their anxiety (first theme), given that the respondents’ asthma was monitored by the medical 
team and was, therefore, controlled. Such feedback allowed for reflections suggesting that the 
themes revealed herein emerged from young people with asthma who were also anxious, and 
may, thus, somewhat demonstrate their perception of the impact of asthma rather than the 
consequences of objective pulmonary function. This is consistent with evidence regarding 




symptom overperception amongst highly anxious children and adolescents with asthma 
(Chen et al., 2006). Finally, they indicated that it was encouraging to see the subthemes 
regarding the ‘medicalised’ ways of managing with anxiety and the over-generalisation of 
asthma strategies to coping with anxiety. They reported that they often observe such 
behaviours in clinics and not enough consideration has been given in their practice to the 
possibility that this may be counterproductive for anxiety, potentially maintaining it.   
Discussions with the nurses and some of the parents, also pointed to the unclear distinctions 
between the subthemes referring to the interaction between asthma and anxiety, as initially 
presented to respondents and important stakeholders (see Appendix I for details). Supervision 
facilitated reflection on how the second subtheme (“working together to make things worse”, 
which was referring to the cumulative impact of experiencing any comorbidity -in this case 
asthma and anxiety) was less directly relevant to the research question and was, therefore, not 
included in the final report.  
4.5. Quality assurance   
The principles outlined by Yardley (2000; 2008) were followed to promote quality and rigour 
in the research. Sensitivity to context was attained by extensively engaging with available 
evidence within this field and reflecting on the lead author’s pre-existing clinical experience 
in respiratory health and treatment of anxiety. In addition, reflexivity (as briefly outlined in 
the prologue) allowed a consideration of the influence of the setting of the study and the main 
researcher’s assumptions and role on the data participants chose to share.  
Commitment was endeavoured by ensuring a prolonged immersion in the data. This was 
demonstrated by undertaking 11 in-depth interviews with a narrowly defined sample, which 
were transcribed and repeatedly read for the analysis, twice alongside audio-recordings, in 
addition to conducting three pilot interviews. Rigour was attempted by applying a random 




recruitment procedure to reduce bias in the initial selection process, implementing strict 
empirically-based eligibility criteria to ensure a highly homogeneous representative sample 
and focusing the research question in a closely defined aspect of participants’ experience. 
Furthermore, a random selection of transcripts were second-coded independently by the main 
researcher’s clinical supervisor, who is experienced in the clinical field and IPA 
methodology. High level of agreement in the emergent themes was achieved and a consensus 
was reached in the super-ordinate themes through supervision. Respondent validation and 
important stakeholder validation was also sought, by posting an initial summary of the results 
to families and carefully considering how these cover, or not, young people’s and their 
parents’ experiences and understandings of the phenomenon. This included seeking 
validation of the original findings through the specialist respiratory nurses involved in this 
project and incorporating everyone’s feedback and interpretations in the final report, where 
appropriate.  
Coherence was displayed by thoroughly considering the choice of qualitative methodology to 
fit with the study aims, by following the standardised procedures recommended (Smith et al., 
2009) and narrating findings in a manner that informed existing knowledge in this field. 
Transparency was demonstrated by detailing the stages of recruitment, data collection and 
analysis, including summary tables, theme prevalence across and within participants and 
samples of analysis (Appendix J), and maintaining an audit trail of decisions, reflections and 
pathway that led to the final report.  
Impact and importance may be demonstrated by reviewing the rationale that led to the design 
of this study, as outlined in the introduction of the main journal article, which was effectively 
to respond to a specific gap in existing knowledge as highlighted by key researchers and 
national guidelines in this field. The multiple potential clinical implications of the findings as 




described in the discussion of the journal article also responded to this evaluative criterion.  
Other guidance to increase the credibility and trustworthiness of the data was also considered. 
For example, careful consideration was paid to the IPA evaluative criteria as specified by 
Smith (2011); in particular on the factors not emphasised in Yardley’s (2000) main 
recommendations, i.e., maintaining a balanced consideration between patterns of divergence 
and convergence in the data, pre-setting measures of minimum prevalence of reported themes 
amongst participants (in at least 1/3), and ensuring enough extracts were presented to support 
each theme.   
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APPENDIX A  
Author guidelines for the Journal of Anxiety Disorders 
Editorial guidance 
The Journal of Anxiety Disorders publishes articles of relevance to the epidemiology, psychopathology, 
etiology, assessment, treatment, and prevention of the anxiety disorders in both child and adult 
populations. The format of the articles includes randomized controlled trials, single case clinical outcome 
studies, theoretical expositions, epidemiological studies, early mechanisms of risk, genetic and biomarker 
studies, neuroimaging studies, critical literature reviews, meta-analyses, and dissemination and 
implementation studies. We are also interested in evaluations of novel treatment delivery strategies, 
including the use of information technologies. Authors are encouraged to use methodologically rigorous 
sampling, structured or semistructured diagnostic interviews, randomization, therapist fidelity, and inter-
rater reliability procedures where appropriate. With the exponential increase in the number of submissions 
to the journal over the last several years, there has been a need to make difficult decisions regarding the 
type of manuscripts that we believe are most relevant and useful to JAD readers. Although analogue 
studies and studies using non-clinical samples often are excellent approaches to controlled research, 
particularly in the area of etiology, others represent only very minor variations on repetitive themes, failing 
to advance the field in any meaningful way. Therefore, given limited journal space, we will no longer 
accept studies based on analogue samples unless they use a tightly controlled experimental design in order 
to enhance our understanding of etiology. 
Language (usage and editing services) 
Please write your text in good English (American or British usage is accepted, but not a mixture of these). 
Authors who feel their English language manuscript may require editing to eliminate possible grammatical 
or spelling errors and to conform to correct scientific English may wish to use the English Language 
Editing service available from Elsevier's WebShop (http://webshop.elsevier.com/languageediting/) or visit 
our customer support site (http://support.elsevier.com) for more information. 
References 
There are no strict requirements on reference formatting at submission. References can be in any style or 
format as long as the style is consistent. Where applicable, author(s) name(s), journal title/book title, 
chapter title/article title, year of publication, volume number/book chapter and the pagination must be 
present. Use of DOI is highly encouraged. The reference style used by the journal will be applied to the 
accepted article by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for 
the author to correct. 
Formatting requirements 
There are no strict formatting requirements but all manuscripts must contain the essential elements needed 
to convey your manuscript, for example Abstract, Keywords, Introduction, Materials and Methods, 
Results, Conclusions, Artwork and Tables with Captions. If your article includes any Videos and/or other 
Supplementary material, this should be included in your initial submission for peer review purposes.  
Divide the article into clearly defined sections. 
Article structure 
Subdivision - numbered sections 
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 




1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for 
internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading. Each 
heading should appear on its own separate line. 
Introduction 
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey 
or a summary of the results. 
Material and methods 
Provide sufficient detail to allow the work to be reproduced. Methods already published should be 
indicated by a reference: only relevant modifications should be described. 
Theory/calculation 
A Theory section should extend, not repeat, the background to the article already dealt with in the 
Introduction and lay the foundation for further work. In contrast, a Calculation section represents a 
practical development from a theoretical basis. 
Results 
Results should be clear and concise. 
Discussion 
This should explore the significance of the results of the work, not repeat them. A combined Results and 
Discussion section is often appropriate. Avoid extensive citations and discussion of published literature. 
Conclusions 
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone 
or form a subsection of a Discussion or Results and Discussion section. 
Abstract 
A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the 
principal results and major conclusions. An abstract is often presented separately from the article, so it 
must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the 
author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential 
they must be defined at their first mention in the abstract itself. The abstract should not exceed 150 words 
in length and should be submitted on a separate page following the title page. 
Highlights 
Highlights are mandatory for this journal. They consist of a short collection of bullet points that convey the 
core findings of the article and should be submitted in a separate editable file in the online submission 
system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, 
including spaces, per bullet point). See http://www.elsevier.com/highlights for examples. 
Keywords 
Include a list of four to six keywords following the Abstract. Keywords should be selected from the APA 
list of index descriptors unless otherwise approved by the Editor. 




APPENDIX B  
Operationalisation of the systematic review quality criteria 
1. Study design provides sufficient evidence that the anxiety outcomes are due to the intervention 
Well covered (3) Experimental - randomised controlled trial 
Adequately addressed (2) Quasi experimental - non randomised controlled trial / multiple baseline 
Poorly addressed (1) Observational - repeated measures design / uncontrolled trial  
Not addressed (0) Observational - single-case design 
2. Recruitment method and inclusion criteria are appropriate to ensure a representative and suitable sample 
Well covered (3) 
A representative recruitment procedure (e.g., random sampling) is applied to reduce selection bias & 
appropriate sample eligibility criteria are applied to address the review aims (e.g., asthma, anxiety 
levels). 
Adequately addressed (2) 
A convenience recruitment procedure is applied, but appropriate attempts have been made to address 
sample representativeness or participants’ inclusion criteria are only adequately appropriate to address 
the review aims. 
Poorly addressed (1) 
Convenience recruitment procedure without sufficient attempts to reduce bias in sample selection or 
participants inappropriate to address the review aims. 
Not addressed (0) 
Recruitment method inappropriate or poorly described & no attempt to apply eligibility criteria or 
address participants’ characteristics. 
3. Sample size (power) is sufficient for analysis relating to pre and post anxiety outcomes 
Well covered (3) 
Number of participants who completed both pre & post measures in the intervention group is sufficient 
to achieve Power of at least 0.8, where effect size is anticipated to be medium & alpha is 0.05. 
Adequately addressed (2) 
Number of participants who completed both pre & post measures in the intervention group is sufficient 
to achieve Power of at least 0.7, where effect size is anticipated to be medium & alpha is 0.05. 
Poorly addressed (1) 
Number of participants who completed both pre & post measures in the intervention group is sufficient 
to achieve Power of less than 0.7, where effect size is anticipated to be medium & alpha is 0.05. 
Not addressed (0) Sample size not reported. 
4. Allocation process is appropriate to address allocation bias 
Well covered (3) 
Appropriate process of allocation to treatment groups is applied to address bias & investigator(s) are 
blinded (e.g., random allocation). 
Adequately addressed (2) Only adequate process of allocation to groups is used to address bias (i.e., poor randomisation method). 
Poorly addressed (1) Control group not randomised.  
Not addressed (0) No control group. 
5. Groups are comparable at baseline on key variables (i.e., asthma or anxiety severity, age, gender) 
Well covered (3) 
The treatment & control groups comparable at baseline or sufficient attempts have been made to 
statistically control for the differences. 
Adequately addressed (2) 
The treatment & control groups only adequately comparable at baseline or only adequate attempts have 
been made to control for the differences. 
Poorly addressed (1) 
The treatment & control groups are not comparable at baseline or no attempts have been made to 
address the differences. 
Not addressed (0) No control group. 
6. Measures of anxiety are robust, appropriately administered and well-validated 
Well covered (3) 
The primary anxiety measures are clearly suitable, valid, reliable, standardised & appropriately 
administered. 
Adequately addressed (2) Most primary anxiety measures are only adequately appropriate, valid, reliable, standardised or only 





Poorly addressed (1) 
Less than 50% of the primary anxiety measures are adequately appropriate, valid & reliable or 
adequately administered.   
Not addressed (0) Not appropriate primary anxiety measures are selected or these are inappropriately administered.  
7. Follow-up measures are administered to evaluate if effects are maintained long-term 
Well covered (3) Follow-up anxiety measures ≥ 12 months  
Adequately addressed (2) Follow-up anxiety measures ≥ 6 months  
Poorly addressed (1) Follow-up anxiety measures < 6 months. 
Not addressed (0) No follow-up anxiety measures administered.  
8. Treatment protocol is suitable for improving anxiety outcomes in the context of asthma 
Well covered (3) 
A sufficiently detailed CBT treatment protocol is used & this is appropriate to improve anxiety 
outcomes (e.g., sufficient number of sessions, clear & valid protocol rationale/content, sufficient level 
of therapist input). 
Adequately addressed (2) 
An adequately detailed CBT protocol is used or this is only partially appropriate to improve anxiety 
outcomes (number of sessions, protocol rationale/content, level of therapist input). 
Poorly addressed (1) 
The CBT protocol is not sufficient to ensure reliability or it is not adequate to improve anxiety 
outcomes (number of sessions, protocol rationale/content, level of therapist input). 
Not addressed (0) No treatment protocol is used.  
9. Intervention is appropriately conducted and adherence to protocol is suitably assessed 
Well covered (3) 
Intervention is carried out by experienced therapists in CBT, & sufficient procedures are available to 
ensure treatment is applied accurately & consistently (e.g. standardised measure to assess adherence, or 
recording & close supervision). 
Adequately addressed (2) 
Intervention is carried out by adequately trained therapists or only adequate procedures to ensure 
adherence to treatment are used.  
Poorly addressed (1) 
Intervention is not carried out by suitably trained therapists or not appropriate procedures to ensure 
treatment fidelity are used. 
Not addressed (0) No information about the therapists’ background or procedure to assess treatment fidelity. 
10. Analysis is appropriate for the study aims, measures or design and outcomes are appropriately reported 
Well covered (3) 
An appropriate statistical analysis is conducted (excl. missing data analysis) & the outcomes are 
appropriately reported. 
Adequately addressed (2) 
An adequately appropriate statistical analysis is conducted (excl. missing data analysis) or the 
outcomes are only adequately reported. 
Poorly addressed (1) Inappropriate or poorly conducted statistical analysis is used or the outcomes are poorly reported. 
Not addressed (0) Statistical analysis not carried out or not reported. 
11. Attrition rates are low or comparable to control group 
Well covered (3) Attrition rates are low (≤20%) or equivalent to control group at post-treatment & follow-up. 
Adequately addressed (2) 
Attrition rates are moderate (≤40%) or moderately different from control group at post-treatment & 
follow-up. 
Poorly addressed (1) Attrition rates are high or differ substantially from control group at post-treatment & follow-up.  
Not addressed (0) Attrition rates not reported or considered.   
12. Method to address missing data is suitable 
Well covered (3) 
No missing data or a suitable method to address missing data is used (e.g., intention to treat analysis, 
maximum likelihood estimation). 
Adequately addressed (2) An adequate method to address missing data is used. 
Poorly addressed (1) Missing data are poorly addressed.  
Not addressed (0) No attempt to consider missing data in the analysis.   
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Parent/guardian and young people information sheets and forms 






Dear parent / guardian, 
 
Your child is being invited to take part in a research study that is being conducted as part of my 
Doctorate degree in Clinical Psychology with the University of Edinburgh and the NHS.  
 
Before you and your child agree to take part it is important that you understand what this 
research involves and why it is being done. Please take time to read the following information 
carefully. Please contact me (Eleni Pateraki, Trainee Clinical Psychologist), if there is anything 
that is not clear or if you would like more information. 
 
Title of the project: 
 
The interaction between childhood asthma, anxiety and medication use: Exploring children 
and young people’s perspectives and attributions. 
 
What is the purpose of the study? 
The aim of the study is to help us understand children and young people’s experiences and 
thoughts about asthma, anxiety and medication use. It appears that this issue has not been 
sufficiently explored and this research is expected to provide us with valuable information 
about how to improve the assessment and treatment of both difficulties when they occur 
together.  
 
Why has my child been chosen? 
Your child is invited because he/she has asthma and is aged between 10 and 16 years. 
 
Does he/she have to take part? 
No. Your child’s participation in the study will be voluntary and their responses will remain 
confidential and anonymous. If you do decide to take part, you and your child will be asked to 
sign a consent forms.  
 
As this study takes place within NHS, if you are invited to an interview, I will write to your GP 
to say that you have agreed to take part. Even if you agree to take part you are still free to 
withdraw at any time and without giving a reason. If you withdraw, your child’s personal data will 
be securely destroyed. A decision to withdraw at any time will not interfere with your child’s 
treatment or care or your relationship with staff in any way. 
 
What will happen if my child takes part?  
The research involves the following stages:  
 




1) STAGE ONE:  QUESTIONNAIRES 
 
If you agree to take part, you and your child will need to complete and sign the enclosed 
contact information form and complete the ‘Screening Questionnaire’. The contact 
information is necessary so that I know how to contact you for the second stage of the 
research.  
 
Your child will also need to complete the enclosed anxiety questionnaire, which is 
designed to explore common childhood worries and fears.  
 
You will then need to return all the completed questionnaires and the contact 
information form in the enclosed freepost envelope. If you return these, then I will 
assume that you and your child have agreed to take part at least in this first part of the 
study.  
 
2) STAGE TWO: INTERVIEW 
 
In the second stage of the study, I will contact a small proportion of parents/guardians 
who returned the questionnaires to invite their child to have an interview with me to 
discuss how they feel their asthma and worries or fears interact together. Before we 
start the interview, you can ask questions again about the study and I will ask you and 
your child to sign consent forms that you agree to take part in the study. 
 
The interview will take place in a venue of your choice (e.g. your home, hospital clinic or 
GP surgery, the local library). The length will depend on how much your child wishes to 
share, but I expect it will not be longer than 45-60 minutes. We can have breaks during 
the discussion if required. I do not expect that the questions are going to be upsetting 
or uncomfortable, but if your child feels so we will stop or have break.  
 
I will need to audio-record the interview using two digital recorders to allow me to recall 
the content and analyse the information that your child provides.  
 
3) STAGE THREE: INTERPRETATION 
 
If you and your child agree, I will later ask you to read a brief summary of the analysis 
of all the interviews to help me with the interpretation based on your experience of 
living with asthma. This summary will be completely anonymised. This will happen through 
a telephone conversation at a later stage of the study, after I finish with all the 
interviews of the participants. When we meet for the interview, we can arrange a 
telephone appointment to do this. I do not expect this telephone conversation to last 
more than 10-15 minutes. As we talk I will take notes to make sure I remember the 
ideas and suggestions you made after reading the summary of the analysis.  
 
What are the possible advantages/disadvantages of taking part? 
The study is not intended to be of direct benefit to yourself or your child, but the results are 
expected to contribute in the improvement of NHS services.  
 
In general, people who have taken part in similar studies have found it a positive experience to 
have a chance to feel listened to. In addition, if the score on the questionnaire suggests 
increased anxiety symptoms, I will write back to you to let you know, so that you consider if you 
want to seek support about this though your GP.  
 
 




Will the information be kept confidential?  
Yes, all information will be kept secure, confidential and anonymous. All audio-recordings and 
transcripts will be kept in a locked cabinet within NHS. Your child’s name will be replaced by a 
pseudonym and it will not be possible for your family to be identified in the final reporting of 
the findings. Once the final results are reported, all recordings and transcripts will be securely 
deleted. Fully anonymised data from the study, from which your child could not be identified, 
may be kept in the University of Edinburgh to assist in future research, if you provide consent 
for this.  
 
If during the interview information is disclosed that indicate that your child or others are at 
risk, then I will need to share this information with others outside the research team.  
  
What will happen to the results of the study? 
The results will be submitted to the University of Edinburgh for review and may be presented in 
scientific journals or conferences. Small quotes from the interviews will only be used after 
being made anonymous and any information that might identify your child will be removed.  
 
Can I find out the results? 
Yes. I will write back to you to provide an explanation of the results.  
 
Did anyone else check that the study is ok to do? 
Yes. The West of Scotland Research Ethics Committee, which has the responsibility to 
scrutinise proposals for research on humans, has examined and approved the proposal for this 
study. Data generated as a result of this study will also be available for inspection by regulation 
authorities. 
 
What if there is a problem? 
If you think that you or your child have been harmed by participating in this study, you have the 
right to make a complaint and ask for compensation from the University of Edinburgh, who is 
sponsoring this research. Details can be found by the research team. Also, as a patient of the 
NHS, you have the right to make a complaint through the NHS process. Details can be found 
through your GP. 
 
What to do next? 
If you are willing to take part in this study, please return the questionnaires and the signed 
contact information forms in the freepost envelope. Dependent on the responses on the 
questionnaires, I may subsequently contact you to arrange an interview.  
 
Thank you for taking the time to read and consider the above information! 
 
If you have any questions about the study, we would be happy to discuss it in more detail 
with you. Please contact: 
 
Lead Researcher: 
Eleni Pateraki, Trainee Clinical Psychologist 
Address: Paediatric Psychology Service, Wishaw General Hospital (Level 3), ML2 0DP 
Telephone:  01698 366 754 
 
Supervisors: 
Dr Paul Graham Morris  
Address: The University of Edinburgh,  
Medical Quad, Teviot Place, EH8 9AG 
Telephone: 0131 651 3956 
Dr Yvonne Vance 
Address: Paediatric Psychology Service, 
Wishaw General Hospital (Level 3), ML2 0DP 
Telephone: 01698 366754 











You are being invited to take part in a study that is being carried out as part of my Doctorate 
degree in Clinical Psychology with the University of Edinburgh and the NHS.  
 
Before you take part it is important that you understand what this research involves and why it 
is being done. Please take time to read the following information carefully. Please contact me 
(Eleni Pateraki, Trainee Clinical Psychologist), if there is anything that is not clear or if you 
would like more information. 
 
Title of the project: 
 
The interaction between childhood asthma, anxiety and medication use: Exploring children 
and young people’s perspectives and attributions. 
 
What is this research about? 
The research is about people’s experiences with asthma, anxiety and 
medication use. We would like to hear what it’s like for you, what thoughts you 
have around these issues and how do you cope with your condition.   
 
Why have I been chosen? 
You are being invited because you have asthma and you are between 10 and 16 years. 
 
Do I have to take part? 
No, you are free to decide if you want to take part. If you do decide to take part, you can 
change your mind anytime without explaining why. If you withdraw, your data will be securely 
destroyed. There will be no consequences for your treatment or your relationship with the staff 
in the asthma clinic.  
 
What will happen if I take part?  
If you decide to take part, the following steps will take place.  
 
1) You and your parent/guardian will need to complete 
the contact information form. You will also need to 
complete the two questionnaires enclosed.   
 
When you finish, please return all the forms to me in the freepost envelope.    
 
2) In the second step, I will meet with some of the people who returned the 
completed questionnaires.  I may meet with you to ask you what it’s like to 
live with asthma, your worries and thoughts about this and how you decide 
to take your medication. This meeting will last less than 60 minutes and we 
can have a break or stop at any point. I will be audio-recording the 
interview so I can remember the information you provided. Before we 
start the interview, you can ask questions and I will ask you and your 




parent to sign consent forms that you agree to take part in the study. 
 
3) When I finish with all the interviews, I will analyse them and make a summary 
of the initial results. This summary will be completely anonymised and it will not 
be possible to identify you in the results. If you agree to help at this stage, I 
will ask you and your parent/guardian to read this brief summary and I will call 
you to tell me what you think and if there are other ways of explaining the 
findings.  
Will I be asked difficult or upsetting questions? 
I will be asking about your asthma, your worries and thoughts about it. Hopefully this won’t be 
upsetting. You can decide not to answer a difficult question, to stop or have a break.  
 
Will my information be kept private?  
Yes, all information will be locked away and remain private. However, if you say 
something that makes me worried about you or someone else, I will have to say to 
your parent/guardian and your GP. Also, if the questionnaire shows you have many 
worries and fears, I will write back to your family to let you know and suggest what 
you can do to get help if you want.  
  
What will happen to the results of the study? 
The results will be submitted to the University of Edinburgh and may be presented in scientific 
journals or conferences. Small parts from the interviews will only be used after removing all the 
information that might identify you. If you agree to this, written manuscripts of the interviews 
may be used in future research, only after removing all the information that might identify you. 
 
Can I find out the results? 
Yes. I will send you an explanation of the results.  
 
Did anyone else check that the study is ok to do? 
Yes. The West of Scotland Research Ethics Committee, which has the responsibility to 
check over studies on humans, has checked this proposal and agreed to go ahead.   
 
What if there is a problem? 
If you feel that you have been harmed by this study, you have the right to 
make a complaint to the University of Edinburgh or the NHS. You can get 
details about how to do this from me or your GP.  
 
Thank you for taking the time to read this information! 
 




Eleni Pateraki, Trainee Clinical Psychologist 
Address: Paediatric Psychology Service, Wishaw General Hospital (Level 3) ML2 0DP.  
Telephone:  01698 366 754 
 
Supervisors: 
Dr Paul Graham Morris  
Address: The University of Edinburgh,  
Medical Quad, Teviot Place, EH8 9AG 
Telephone: 0131 651 3956 
Dr Yvonne Vance 
Address: Paediatric Psychology Service, 
Wishaw General Hospital (Level 3), ML2 0DP 
Telephone: 01698 366754 










You are being invited to take part in a study that is being carried out as part of my Doctorate 
degree in Clinical Psychology with the University of Edinburgh and the NHS.  
 
Before you take part, please take the time to read why this research is being done and what it 
involves.   Please contact Eleni Pateraki, who is the lead researcher, if there is anything that is 
not clear or if you would like more information. 
 
Title of the project: 
 
The interaction between childhood asthma, anxiety and medication use: Exploring children 
and young people’s perspectives and attributions. 
 
What is this research about? 
The research is about people’s experiences of asthma, anxiety and medication use. We 
would like to hear what it’s like for you and how do you cope.   
 
Why have I been chosen? 
You are being invited because you have asthma and you are between 10 and 16 years. 
 
Do I have to take part? 
No, you are free to decide if you want to take part. If you do decide to take part, you can 
change your mind anytime without explaining why. If you decide to withdraw, this will not affect 
your treatment with the asthma team.  
 
What will happen if I take part?  
If you decide to take part, the steps below will take place.  
 
1) You and your parent/guardian will need to sign the 
contact information form. You will also need to 
complete the enclosed questionnaires.  
 
When you finish, please return all the forms to me in the freepost envelope.    
 
2) In the second step, I may meet with you to ask you what it’s like to live with 
asthma, your worries and thoughts about this and how you decide to take 
your medication.  
 
This meeting will last less than 60 minutes and we can have a break or stop 
at any point. I will be audio-recording the interview so I can remember the 
information you provided. Before we start the interview, I will ask you and your 
parent/guardian to sign some forms that you agree to take part in this study. 




3) When I finish with all interviews with all the participants, I will make a summary 
of the initial results. This summary will not have anything that might identify 
you. If you agree, I will ask you and your parent/guardian to read it and I will 
call you to tell me what you think and if you have more ideas to help me explain 
the findings.  
 
Will I be asked difficult or upsetting questions? 
I will be asking about your asthma and your worries about it. Hopefully this 
won’t be upsetting. You can decide not to answer a difficult question, to stop or 
have a break.  
 
Will my information be kept private?  
Yes, all information will be locked away and kept private. However, if you say 
something that makes me worried about you or someone else, I will have to 
say to your parent/guardian and your GP. Also, if the questionnaire shows you 
have many worries and fears, I will say to your family and suggest what you 
can do to get help.  
  
What will happen to the results of the study? 
The results will be submitted to the University of Edinburgh for review and may be presented in 
scientific journals or conferences. Small parts from the interviews will only be used after 
removing anything that might identify you. If you agree for this, the interviews may be used in 
future research, only after removing anything that might identify you. 
 
Can I find out the results? 
Yes. I will send you an explanation of the results.  
 
Did anyone else check that the study is ok to do? 
Yes. The West of Scotland Research Ethics Committee, whose job is to check studies 
on humans, has checked this proposal and agreed to go ahead.   
 
What if there is a problem? 
If you feel that you have been harmed by this study, you have the right to make a complaint to 
the University of Edinburgh or the NHS. You can get details about how to do this from me or 
your GP.  
 
Thank you for taking the time to read this information! 
 
If you have any questions about the study, we would be happy to discuss 
these with you. Please contact: 
 
Lead Researcher: 
Eleni Pateraki, Trainee Clinical Psychologist 
Address: Paediatric Psychology Service, Wishaw General Hospital (Level 3) 
ML2 0DP.  
Telephone:  01698 366 754 
 
Supervisors: 
Dr Paul Graham Morris  
Address: The University of Edinburgh,  
Medical Quad, Teviot Place, EH8 9AG 
Telephone: 0131 651 3956 
Dr Yvonne Vance 
Address: Paediatric Psychology Service, 
Wishaw General Hospital (Level 3), ML2 0DP 
Telephone: 01698 366754 








The interaction between childhood asthma, anxiety and medication use: Exploring 




To be completed with help from parent(s) or guardian(s) 
 
 
Please answer the questions below to the best of your knowledge.  
 
 
What is your date of birth? 
 
____/____/______ 
What is your age? 
 
_______ years 
You are being invited to this study because you suffer from childhood asthma.   
How long has it been since you were diagnosed with 
asthma? 





Do you have other physical health conditions? 
 
Yes              No  





Have you been diagnosed with a learning disability or a 
developmental disorder? 
 
Yes              No  
If yes, what is your diagnosis? 
 
 
Are you currently suffering from a mental health or 
emotional difficulty?  
 
Yes              No  
               If yes, what is your difficulty? 
 
 
Are you currently receiving help for anxiety? 
 
Yes              No  
Are you fluent in English language?  Yes              No  







CONTACT INFORMATION FORM 
(to be completed by parent/guardian and child/young person) 
 
 
Title of the project:  The interaction between childhood asthma, anxiety and medication 
use: Exploring children and young people’s perspectives and 
attributions. 
 
Name of Lead Researcher: Eleni Pateraki, Trainee Clinical Psychologist 
 
  
I agree to Eleni Pateraki, Trainee Clinical Psychologist contacting me to discuss 




Name of child/young person:_________________________________________ 
Name of parent or guardian: _________________________________________ 





PLEASE PROVIDE YOUR TELEPHONE NUMBER TO ALLOW ME TO CONTACT 
YOU TO ARRANGE A CONVENIENT TIME/PLACE FOR THE INTERVIEW. 
 
Telephone number: ___________________________________________ 
Mobile number: ______________________________________________  
 
If you have an answerphone, is it OK to leave a message?    YES    NO     
 
 
Please provide your child’s GP details, so I can inform them regarding your child’s 
participation in the research.  
 






Telephone number: __________________________________________________ 
 
 
_____________________    ___________________  _____________ 




_____________________    ___________________  _____________ 
Name of Young Person  Signature    Date 











PARENT/GUARDIAN CONSENT FORM 
 
 
Title of the project:  The interaction between childhood asthma, anxiety and medication 









I confirm that I have read and understand the information sheet for the above study. 





I understand that my child’s participation is voluntary and we have the right to 









I understand that small anonymised parts of my child’s interview may be used for 
publication in reports. I understand that should this happen, my child will not be 









I consent to fully anonymised and unidentifiable data from my child’s participation to 
the study being kept in the University of Edinburgh to assist in future research. 
  
 
_____________________    ___________________  _____________ 
Name of Parent/Guardian  Signature    Date 
 
 
_____________________    ___________________  _____________ 
Name of Researcher   Signature    Date 









PARENT/GUARDIAN ASSENT FORM 
 
 
Title of the project:  The interaction between childhood asthma, anxiety and medication 









I confirm that I have read and understand the information sheet for the above 
study. I have been offered the opportunity to ask questions and these have 




I understand that my child’s participation is voluntary and we have the right 









I understand that small anonymised parts of my child’s interview may be 
used for publication in reports. I understand that should this happen, my child 
will not be identified from any of the information provided. 
 
 





I agree to fully anonymised and unidentifiable data from my child’s 






_____________________    ___________________  _____________ 





_____________________    ___________________  _____________ 
Name of Researcher   Signature    Date 








YOUNG PERSON CONSENT FORM 
 
 
Title of the project:  The interaction between childhood asthma, anxiety and medication 




Name of Lead Researcher: Eleni Pateraki, Trainee Clinical Psychologist 
 
 
Please read the following statements carefully. If you are happy with each statement 
please tick the box. 
 
 
I have read and I understand the information sheet for the above study. I 





I understand that I don’t need to take part and I can withdraw from the study 









I understand that small parts of my interview may be used for reports. I 
understand that if this happens, all the information that might identify me will 










I consent to my responses being kept in the University of Edinburgh to help 






_______________________    ___________________  _____________ 





_____________________    ___________________  _____________ 
Name of Researcher   Signature    Date 









YOUNG PERSON ASSENT FORM 
 
 
Title of the project:  The interaction between childhood asthma, anxiety and medication 




Name of Lead Researcher: Eleni Pateraki, Trainee Clinical Psychologist 
 
 
Please read the following statements carefully. If you are happy with each statement 
please tick the box. 
 
 
I have read and I understand the information sheet for the above study. I 





I understand that I don’t need to take part and I can withdraw from the study 









I understand that small parts of my interview may be used for reports. I 
understand that if this happens, all the information that might identify me will 










I agree to my answers being kept in the University of Edinburgh to help with 





_______________________    ___________________  _____________ 





_____________________    ___________________  _____________ 
Name of Researcher   Signature    Date 
 












Trainee Clinical Psychologist 
Paediatric Psychology Service (CAMHS) 
__Address of service__ 
 
Date: __/__/__ 
Name/address of GP 
 
Dear Dr__(Name of GP)___ 
 
Re: ___(Patient name and date of birth)___ 
 
I am writing to advise that the above named young person and their parent/guardian have 
agreed to take part in the research project I am undertaking in part fulfilment of the 
requirements of the Doctorate degree in Clinical Psychology with the University of 
Edinburgh and the NHS.  
 
Study title:  The interaction between childhood asthma, anxiety and medication use: 
Exploring children and young people’s perspectives and attributions.  
REC reference:  13/WS/0318  
R&D Project No:  2014/0051 
 
The research will be adopting a qualitative methodology using a purposeful random sampling 
procedure. In-depth semi-structured individual interviews with children and young people 
will be used to gather data. The West of Scotland Research Ethics Committee has scrutinised 
and approved the proposal for this study.  
 
Please find enclosed the information sheet sent to parents/guardians and children/young 
people for further information. Please do not hesitate to contact me, should you wish to 





Eleni Pateraki   Supervised by Dr Paul Graham Morris 
Trainee Clinical Psychologist   Lecturer in Health Psychology 
and 
Dr Yvonne Vance  
Clinical Psychologist 















Trainee Clinical Psychologist 
__Address of Service__ 
Date: __/__/__ 
Parent/guardian of: 
__(Name of potential participant)__ 
Address 
 
Dear parent/guardian  
 
Study title:  The interaction between childhood asthma, anxiety and medication use: 
Exploring children and young people’s perspectives and attributions.  
REC reference:  13/WS/0318  
R&D Project No:  2014/0051 
 
Thank you for agreeing to support my research project. As discussed in my initial 
correspondence, I am writing back to all families of children and young people who scored 
higher on the anxiety questionnaire to advise them of this.  
 
Although a high score on a single anxiety questionnaire cannot be the only source of 
information to make conclusions regarding the presence of an anxiety difficulty, it may 
suggest that the reported worries could require further exploration. If you think your child’s 
fears or worries are troubling, here are some websites which may be of value: 
 
www.kidshealth.org/  www.handsonscotland.co.uk/       www.moodjuice.scot.nhs.uk/ 
 
You can also discuss this with your GP if you feel that this is appropriate at this stage.  
 
I hope you find the above information useful. In relation to the research process, I may still 
contact you to invite your child to the interview.  
 





Eleni Pateraki    Supervised by: Dr Paul Graham Morris 
Trainee Clinical Psychologist                 Lecturer in Health Psychology 
   and 
   Dr Yvonne Vance  
   Clinical Psychologist 








 Discuss the information sheet and provide another opportunity for both 
parents/guardians and children/young people to ask questions. 
 Discuss and sign consent/assent forms. 
 Discuss the interview schedule to set the context of the interview. 
Prompts: If the word anxiety is difficult to comprehend, consider alternatives:  
feeling nervous, scared, worried, being apprehensive.  
 
A. Experience of conditions separately. 
- Can you talk to me about what is asthma like for you?  
How does it affect your life? 
- How do you feel about your asthma? What has it meant for your life? 
Prompts: day-to-day functioning/activities, relationships, coping strategies, 
medication, role of parents. 
- Can you talk to me about what is anxiety like for you? 
 How does anxiety affect your life? 
- What do you think about your anxiety? What has it meant for your life? 
Prompts: types of worries, examples of worrying situations, day-to-day 
functioning/activities, relationships, coping strategies, role of parents. 
 
B. Relationship between anxiety and asthma 
- Do asthma and anxiety sometimes influence or affect one another?  
Prompts: consider alternatives, e.g. happen at the same time/occur together. 
When are they more likely to occur together? What happens before/after? 
Prompts: thoughts, feelings, behaviours, bodily symptoms. 
- How do you cope when asthma and anxiety occur together?  
How do you try to improve your symptoms then?  
What would make your anxiety and asthma better? 
Prompts: strategies, behaviours, role of parents, role of medication. 
- Does your anxiety impact on your asthma? If yes, how? 
- Does your asthma impact on your anxiety? If yes, how? 
- What sort of worries do you have about your asthma? 
When do you worry about your asthma? 
What sort of thoughts/worries do you have when you have an asthma episode?  




What are your expectations about your asthma and anxiety in the future? 
Prompts: explanations, predictions about the future, impact on 
functioning/relationships, identity/how others perceive them. 
- How does worrying feel on your body? How is that different from asthma?  
Do you ever confuse the two? If yes, please tell me about that. 
- How do you know when to get your medication?  
Prompts: asthma symptoms monitoring, role of parents, medication plan changes. 
 
C. How was this interview for you? 
 
Additional prompts: 
• I’m interested in / Can you tell me more about that? 
• What do you mean by that? 
• Can you give me an example? / What did you do? 
• How do you feel/think about that? 
 
 





Respondent validation letter and summary of initial themes 











Trainee Clinical Psychologist 
Paediatric Psychology Service (CAMHS) 
Level 3, Wishaw General Hospital 
50 Netherton Street 
ML2 0DP 




__name of the child__ 
 
Dear *name of the child*  and parent/guardian  
 
Study title:  The interaction between childhood asthma, anxiety and medication use: 
Exploring children and young people’s perspectives and attributions.  
REC reference:  13/WS/0318  
R&D Project No:  2014/0051 
 
 
Thank you for recently participating in my study exploring the relationship between asthma 
and anxiety. I have now completed the initial analysis of all the interviews with young people 
with similar difficulties. 
 
As discussed during our appointment, I am writing back to provide you with a brief summary 
of the most common themes that came up from the analysis with examples directly taken 
from the interviews. This summary refers to all the interviews and some of the themes may 
not be relevant to __name of the child__.   
 
If you still wish to participate in this third stage of the study, please read the enclosed 
summary. I will call you in approximately 10 days to discuss your and __name of the child__ 
thoughts on these initial results. 
 
I will be asking you questions such as: Are these similar or different to your experience of 
living with asthma or bringing up a child with asthma? Have I covered all the areas that are 
important to you? Is there another way of viewing the results?  
 




I do not expect this telephone conversation to last more than 10-15 minutes. As we talk I will 
take notes to make sure I remember the ideas and suggestions you made after reading the 
summary of the analysis. If I cannot reach you by the phone, please feel free to post any 
comments to me. Your feedback will be greatly appreciated.  
 






Eleni Pateraki    Supervised by: Dr Paul G. Morris 
Trainee Clinical Psychologist                Lecturer in Health Psychology     
and 
Dr Yvonne Vance  
Clinical Psychologist 
 




PART II: Summary of initial themes  
 
Key themes from the interviews: 
 
THE IMPACT OF ASTHMA ON ANXIETY SYMPTOMS 
1. Asthma as a threat to important goals of development in adolescence.  
 Influencing the development of identity: “you couldn’t join in with stuff...  you felt the odd one 
out”  
 Achieving age-appropriate independence: “I’d always be with someone... just in case anything 
happens... I don’t like the fact that I go out and can’t do stuff myself” 
 Forming friendships: “Very upsetting because all my friends are always with each other and 
sometimes I can’t be with them and then I start drifting away from them and I don’t get to see 
them” 
2. Asthma triggers worrying thoughts  
 Asthma as a theme to worries: “It’s just something that goes on, like, everyone else worries about 
something else, I worry about asthma.” 
 Predicting disasters, catastrophising: “I just get really... panicky (when experiencing asthma 
symptoms) What do I do? What’s going to happen? Am I going to be OK? Is it going to get worse 
now?” 
 Worrying about impact on important others: “I’m putting like pressure on other people who have 
to look after for me. I don’t like it very much” 
3. Strategies to manage asthma may generalise to managing anxiety and may maintain anxiety 
 Being vigilant for asthma triggers may generalise to being constantly vigilant about anything 
unsettling, hindering relaxation: “Well, the asthma affects ...just almost everything I do, because I 
always have to worry... I just have to think of all the things that might happen and then almost 
prepare for them” 
 Medication and being around helpful others is important for asthma, but may generalise to 
constantly seeking safety in them to feel safe and relaxed: “I make sure I’ve got, like, spare 
inhalers in case I lose one and I bring three... I will never need three... but I get almost worried 
that I will use it and then I will run out of inhalers and then I will get an asthma attack” 
 Coping with anxiety may become very medical: “I get headaches... when I’m nervous... I would 
then take Paracetamol and then just like cope until I go home... go to bed and lie down” 
4.  Asthma acts as a barrier to activities that are valued and possibly stress-relieving 
 Asthma hinders engagement in activities that are valued: “I miss a lot of learning in 
school”;“That’s when it was particularly bad, when I was much younger it affected my entire life 
basically; my education; my fitness; everything” 




 Asthma hinders engagement in activities that help to cope with anxiety: “like doing sports just 
takes me to another place really. It just takes me away from everything... before I had asthma... I 
used to be really sporty. I still love sports and my asthma pulls me back”; 
 
THE IMPACT OF ANXIETY ON ASTHMA SYMPTOMS 
1. Physical symptoms of anxiety and anxiety-related behaviours trigger asthma symptoms 
“it’s not really the fright it’s more the sudden faster breathing that kind of brings on the asthma” 
“Sometimes if I start crying and stuff it’ll affect my asthma because when I cry I can’t breathe” 
2. Anxiety inhibits good asthma care and medication adherence 
 “When I have an asthma attack... I won’t just sit down and take a deep breath, I’ll be like, “What 
do I do, what do I do?” stuff like that. And then usually when I’m worried... The times in the past 
that I’ve had an asthma attack or my asthma’s been really bad, I hadn’t taken my inhaler properly 
because I’d been that worried...”  
“It is more if I have to take my inhaler in front of people; I don’t like doing that, ‘cos they might 
think I’m on drugs or something” 
 
THE INTERACTION BETWEEN ASTHMA AND ANXIETY 
1. Asthma and anxiety interact forming a vicious cycle of one leading to the other 
 “Scary, it was…Whenever I had the asthma attack it would then turn into a panic attack and 
make that worse because I was scared of it, so then my breathing would get worse, my hands and 
feet I couldn’t feel them and I just couldn’t breathe” 
“If I ever had an asthma attack it would make me nervous and anxious so and then I would get 
worked up and it would make the asthma worse.  Then because the asthma would get worse I 
would get more anxious, it would keep going and both would get worse, and worse, and worse 
until my asthma was really bad and we would have to phone an ambulance and go to hospital” 
2. Asthma and anxiety work together to make things worse  
“I feel they’re interacting because like, it feels like if [pause] say like my worrying is like it’s 
trying to help my asthma beat me…beat like…[sighs] beat me!...It’s like they’ll help, try help each 
other like to  beat me up”  
3. Confusion between symptoms of asthma and symptoms of anxiety 
“Well, I was playing football and ... I was running around quite a lot and then I was, like right, I 
need to take my inhaler. I don’t have it, and then I started really worrying and then that caused me 
to actually have an asthma attack.  So I needed to go and get an inhaler.  That probably… if I 
realised I don’t have asthma, I just sit down and make sure I breathe slower, then I would be fine” 
“I was sitting there – I think I was worrying, but then... I can just remember worrying and then 
taking my inhaler. So then I don’t know if that was one of the two.” 






Prevalence of themes across participants
4
 
Subthemes Jennifer John Ben Amy Craig Clare Simon Lucas Richard Liz Chris 
The influence of asthma 
Asthma as a threat to important 
developmental goals            
Asthma as a barrier to valued, 
potentially coping, activities            
Asthma triggers worries and 
anxiety-provoking thinking patterns            
Strategies to manage asthma over-
generalise to managing anxiety             
The influence of anxiety 
Physical symptoms of anxiety and 
anxiety-related behaviours trigger 
asthma  
           
Anxiety inhibits good asthma care 
and medication adherence  
          
     The interaction between asthma and anxiety 
Asthma and anxiety interact 
forming a positive feedback loop            
Confusion between symptoms of 
asthma and symptoms of anxiety            
 
 
                                                          
4
 Participants’ names were replaced with pseudonyms to protect confidentiality. 





Example of initial coding process 
Emergent 
themes 













Anxiety impacts on 
asthma – taking over 



























anxiety during an 
I: Right. So you’ve told me a little bit about what is 
worrying and anxiety like for you and you explained 
what asthma is like for you, and medication, etc. Do 
asthma and anxiety sometimes affect one another? 
P: Yeah. 
I: In what way? 
P: When I have an asthma attack I’m just saying, for 
example, then I will get really worried and I’ll get 
quite panicky and I won’t just sit down and take a 
deep breath, I’ll be like, “What do I do, what do I 
do?” stuff like that. And then usually when I’m 
worried... The times in the past that I’ve had an 
asthma attack or my asthma’s been really bad, I 
hadn’t taken my inhaler properly because I’d been 
that worried. I get confused, that kind of feeling. 
Then my mum would need to give me my inhaler 
just because I’d be too worried and too unsettled. 
I: So what you’re saying is when asthma and anxiety 
kind of occur together, for example in an asthma 
attack, then you get a bit confused about how to use 
medication and you get... 
P: Uh-huh, I just get really confused and worried and 
panicky. “What do I do? What’s going to happen? 
Am I going to be OK?” That kind of a.... 
I: Yeah. And how do you manage when these thoughts 
go through your mind? “What do I do? What’s 
going to happen?” 
P: I don’t manage it, my mum does. My mum gets me 
sat down, gets me calm again, gets me to take my 
inhaler... 
I: Right. And how about when mum is not around? 
P: Then I just go in a complete panic. If I’m with 
anyone, then they’ll... we’ll both try and calm down. 















Role of important 
others to guide 
when anxiety is 
overwhelming - 













Role of parents – 
reliance on mother 
Important others 
help - take the lead 
in treatment 
 
Others crucial in 
managing during an 
asthma episode. 















anxiety – resolved 
















issues leading to 
breathlessness, 
















best to take my inhaler, just calm down, take a deep 
breath. 
I: OK. And can you tell me the sort of situation when 
you are more likely to get panicky, during an asthma 
attack, for example? 
P: When I have an asthma attack I get out of breath and 
I cough and I just wheeze or whatever happens at 
that time then I’ll get quite worried. Then, because 
I’m worried I’ll start thinking about, “Where’s my 
inhaler? What do I do now? Am I going to be OK? 
What’s going to happen? Is this going to affect me 
even more?” And then I’ll be even more worried. So 
it’s like one stage after another. 
I: And then does worrying affect your asthma? 
P: Yeah, yeah. 
I: In what way? Can you explain a little bit more about 
that? 
P: As I say, I’m just sitting thinking about if people 
like me or what’s going to happen in the future, then 
obviously I’ll just get over the top basically and  I’ll 
think about it too deep in and then I won’t get it out 
of my head, basically. It’ll just stay in there. I won’t 
maybe think about it but then I’ll start thinking 
about it, it’ll stay at that position so I’ll still be quite 
worried and then I’ll get out of breath. I might need 
my inhaler just because... I might be talking to 
myself or something about it and then I just get 
really worried and panicky. When I worry about 
things like that I just start to get panicky and when 
it’s quite panicky then my asthma kicks in and that’s 
when I need an inhaler or I need to sit down or 
something like that. 
I: And how do you manage when these kind of things 
happen? 
P: I honestly don’t know. I guess I just kind of take my 
inhaler and then just try to calm down and stuff like 









during an asthma 
episode - ‘what 
if(s)’ 
Worrying about the 
long-term impact of 
asthma and how the 














Anxiety and asthma 
in a vicious cycle? 
Would that lead to 
worry about the 
asthma symptoms as 
described earlier? 
Inhalers help stop 




Role of medication 
Cycle only triggered 
when anxiety is 
increased – problem 
is severe 
 
